Cluster headache, strict, including avohilmo

G6_CLUSTHEADACHE_STRICT_INCLAVO

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — G44.0 1 out of 7 registries used, show all original rules.	1083
4. Check minimum number of events None	1083
5. Include endpoints G6_CLUSTHEADACHE_STRICT	2056
6. Filter based on genotype QC (FinnGen only)	1969

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF6

NAME	G6_CLUSTHEADACHE_STRICT_INCLAVO
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	G6_CLUSTHEADACHE_STRICT
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	G440
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Cluster headache, strict, including avohilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Cluster headache, strict

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	11512	5294	6127
Only index persons	11219	5224	5995
Unadjusted period prevalence (%)
Whole population	0.16	0.15	0.17
Only index persons	0.21	0.19	0.23
Median age at first event (years)
Whole population	41.46	42.16	40.92
Only index persons	41.26	42.00	40.63

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1969	1216	753
Unadjusted period prevalence (%)	0.40	0.43	0.34
Median age at first event (years)	45.75	44.26	48.16

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2056: Matched controls
20560

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

8.6

307.7

553

841

N02CC03

ATC

zolmitriptan; nasal, oral

11.6

307.7

589

687

G44.0

ICD-10 Finland

Cluster headache syndrome

+∞

307.7

2056

C08DA01

ATC

verapamil; systemic

63.8

307.7

866

232

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

22.7

307.7

1500

2183

G43.9

ICD-10 Finland

Migraine, unspecified

8.7

307.7

560

847

R51.80

ICD-10 Finland

Headache

8.1

307.7

1006

2181

G43.3

ICD-10 Finland

Complicated migraine

18.1

307.7

278

176

N03AX11

ATC

topiramate; oral

25.5

307.7

489

249

N02CC07

ATC

frovatriptan; oral

9.0

292.5

402

539

N02CC04

ATC

rizatriptan; oral

7.7

285.2

460

741

3007

Kela drug reimbursment

Erenumab and fremanezumab

18.5

261.2

214

128

G44.2

ICD-10 Finland

Tension-type headache

5.1

246.4

685

1827

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

6.1

232.7

480

981

G44.8

ICD-10 Finland

Other specified headache syndromes

16.3

224.7

196

132

N03AG01

ATC

valproic acid; systemic, rectal

6.9

218.1

381

659

N03AX12

ATC

[U] gabapentin; oral

4.7

215.5

658

1871

N02CC06

ATC

eletriptan; oral

8.0

211.5

314

455

N02CD01

ATC

erenumab; parenteral

21.1

203.0

155

H02AB06

ATC

prednisolone; systemic

4.1

201.6

1370

6767

N06CA01

ATC

amitriptyline and psycholeptics; systemic

5.2

172.1

415

960

N02CD03

ATC

fremanezumab; systemic

17.0

165.8

140

G43.8

ICD-10 Finland

Other migraine

11.6

164.9

176

165

N06AA09

ATC

amitriptyline; systemic

5.2

157.5

372

842

N89

ICPC

Migraine

6.6

157.0

272

461

G43

ICD-10 Finland

Migraine

5.3

154.9

350

762

N01

ICPC

Headache

4.1

152.7

521

1570

N02CC05

ATC

almotriptan; oral

6.5

152.6

270

467

N03AX16

ATC

[U] pregabalin

3.4

144.1

719

2778

C09CA06

ATC

candesartan; oral

3.3

136.1

722

2881

N02CC02

ATC

naratriptan; oral

10.0

134.9

159

171

R51

ICD-10 Finland

Headache

5.2

130.4

298

651

N02AX02

ATC

tramadol; systemic, rectal

3.0

129.6

1113

5802

M03AX01

ATC

botulinum toxin; parenteral

12.1

129.5

133

117

C07AA05

ATC

propranolol; systemic

3.1

123.2

719

3008

R51.81

ICD-10 Finland

Facial pain NOS

8.9

121.2

156

188

H02AB07

ATC

prednisone; oral

3.8

118.1

439

1384

N02CD02

ATC

galcanezumab; parenteral

28.3

116.8

A03FA01

ATC

metoclopramide; systemic, rectal

3.0

107.4

636

2652

AA1AD

NOMESCO Finland

CT of head and brain

3.0

105.2

634

2665

G43.2

ICD-10 Finland

Status migrainosus

25.7

102.9

N02CX04, ,

ATC

9.7

101.3

121

132

N03AF01

ATC

carbamazepine; oral, rectal

5.5

98.4

204

406

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.6

98.3

1006

5507

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

4.0

96.0

305

855

G50.1

ICD-10 Finland

Atypical facial pain

9.8

93.2

110

118

M01AE02

ATC

naproxen; oral, rectal

2.7

91.5

1446

9612

N90

ICPC

Cluster headache

319.8

90.6

G50.0

ICD-10 Finland

Trigeminal neuralgia

9.5

89.6

108

119

M03BX02

ATC

tizanidine; oral

2.8

89.2

1560

10835

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.7

89.2

320

974

N06AX16

ATC

venlafaxine; oral

2.9

86.3

504

2056

N03AX09

ATC

lamotrigine; oral

4.2

83.2

243

638

N06AX21

ATC

duloxetine; oral

3.1

83.0

406

1496

M03BC01

ATC

orphenadrine (citrate); systemic

2.6

82.7

695

3400

A02BC02

ATC

pantoprazole; systemic

2.6

81.9

1510

10525

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.4

78.3

1098

6718

N02CA52

ATC

ergotamine, combinations excl. psycholeptics; oral

11.3

77.5

M01AE03

ATC

ketoprofen; systemic, rectal

2.4

77.0

856

4727

M01AG02

ATC

tolfenamic acid; oral, rectal

2.8

76.1

486

2064

A02BC05

ATC

esomeprazole; systemic

2.3

73.3

961

5664

N06AX11

ATC

mirtazapine; oral

2.3

73.0

853

4787

N02BF01

ATC

gabapentin; oral

3.6

72.5

266

817

N06AA10

ATC

nortriptyline; systemic

6.9

72.3

115

176

M03BX01

ATC

baclofen; systemic

7.1

72.1

111

164

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.4

71.9

690

3549

C07AB07

ATC

bisoprolol; oral

2.3

71.4

912

5301

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.5

71.4

280

897

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.3

71.2

303

1022

G44

ICD-10 Finland

Other headache syndromes

19.0

65.8

M79.6

ICD-10 Finland

Pain in limb

2.2

65.2

993

6136

R07.4

ICD-10 Finland

Chest pain, unspecified

2.4

63.6

624

3212

M03BC51

ATC

orphenadrine, combinations; systemic

2.3

63.0

720

3950

M54.5

ICD-10 Finland

Low back pain

2.1

60.4

910

5550

N02CD06

ATC

rimegepant; oral

17.9

60.3

C07AB02

ATC

metoprolol; systemic

2.7

60.0

371

1534

R42

ICD-10 Finland

Dizziness and giddiness

2.4

59.9

499

2381

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.8

58.5

190

535

N03AE01

ATC

clonazepam; systemic

3.8

58.4

188

526

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

55.8

618

3318

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.6

55.5

400

1778

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.5

55.2

415

1882

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.2

55.1

692

3902

M54.4

ICD-10 Finland

Lumbago with sciatica

2.4

54.7

488

2390

M79.7

ICD-10 Finland

Fibromyalgia

4.3

53.9

146

360

R06.0

ICD-10 Finland

Dyspnoea

2.2

53.3

570

3009

N05AH04

ATC

quetiapine; oral

2.3

53.2

507

2551

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.6

52.3

349

1492

M01AB05

ATC

diclofenac; systemic, rectal

2.2

52.1

1477

11153

N02AJ06

ATC

codeine and paracetamol; systemic

2.0

52.0

1002

6584

N02CA01

ATC

dihydroergotamine; nasal, systemic

22.8

51.9

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.8

51.6

287

1117

N05AN01

ATC

lithium; oral

4.8

51.6

121

266

N05BA01

ATC

diazepam; systemic, rectal

2.6

51.3

335

1416

R03AC02

ATC

salbutamol; inhalant

2.0

51.1

1266

9066

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

6.3

51.0

146

A02BC03

ATC

lansoprazole; oral

2.1

50.3

612

3387

N02BE01

ATC

paracetamol; systemic, rectal

3.1

49.7

1875

15811

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.3

49.4

456

2255

H57.1

ICD-10 Finland

Ocular pain

4.0

49.3

149

398

N05BA04

ATC

oxazepam; oral

2.1

48.9

610

3404

A01

ICPC

Pain general/multiple sites

2.9

48.7

246

908

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

18.4

47.4

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.7

47.3

293

1203

R53

ICD-10 Finland

Malaise and fatigue

2.1

47.2

568

3120

TPH04

NOMESCO Finland

Cathetrisation of vein

2.2

46.7

479

2468

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.5

45.7

345

1556

M79.0

ICD-10 Finland

Rheumatism, unspecified

4.4

45.6

117

276

R52.2

ICD-10 Finland

Other chronic pain

4.0

44.8

132

346

L03

ICPC

Low back symptom/complaint

2.0

44.6

657

3874

A02BC01

ATC

omeprazole; systemic

2.1

44.6

569

3185

3AX01, ,

NOMESCO Finland

17.1

44.5

L01

ICPC

Neck symptom/complaint

2.3

44.0

414

2054

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

43.9

859

5576

N05CF01

ATC

zopiclone; oral

2.0

43.2

651

3863

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

43.0

442

2272

H02AB04

ATC

methylprednisolone; systemic

2.4

42.8

340

1567

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.2

42.5

176

578

M01AB01

ATC

indometacin; systemic, rectal

3.4

42.4

158

486

M79.1

ICD-10 Finland

Myalgia

2.3

41.5

393

1950

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.8

41.0

228

883

M01AH05

ATC

etoricoxib; oral

1.9

40.9

1375

10534

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

4.2

40.7

112

279

M25.5

ICD-10 Finland

Pain in joint

1.9

40.6

768

4901

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.4

40.4

302

1352

N06AB04

ATC

citalopram; systemic

2.1

40.4

487

2656

G44.1

ICD-10 Finland

Vascular headache, not elsewhere classified

9.4

40.2

R52.9

ICD-10 Finland

Pain, unspecified

2.6

39.9

253

1047

K07.60

ICD-10 Finland

Snapping jaw

3.0

39.9

185

649

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.2

39.7

395

1997

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

3.4

39.7

149

460

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.8

39.5

223

870

N06AB10

ATC

escitalopram; oral

2.0

39.1

557

3221

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.9

38.9

1250

9370

N02AA05

ATC

oxycodone; systemic

2.4

38.7

310

1429

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.7

38.6

219

857

J01AA02

ATC

doxycycline; systemic

2.0

38.5

1597

12980

P01AB01

ATC

metronidazole; oral, rectal

1.8

38.3

889

6023

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

6.1

38.2

113

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

5.0

37.7

169

M35.7

ICD-10 Finland

Hypermobility syndrome

5.4

37.6

143

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.5

37.5

267

1167

R20.2

ICD-10 Finland

Paraesthesia of skin

2.7

37.2

210

819

A02BA02

ATC

ranitidine; systemic

2.2

36.6

372

1892

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.1

36.6

432

2328

TAB00

NOMESCO Finland

Lumbar puncture

3.3

36.5

143

453

A11

ICPC

Chest pain NOS

2.9

36.4

185

682

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

35.5

553

3281

J01FF01

ATC

clindamycin; systemic

1.9

35.5

591

3585

R03DC03

ATC

montelukast; oral

2.1

35.4

419

2257

F45.8

ICD-10 Finland

Other somatoform disorders

2.6

35.3

233

981

D01

ICPC

Abdominal pain/cramps general

2.3

35.3

308

1471

M54.2

ICD-10 Finland

Cervicalgia

2.6

35.2

229

957

H53.1

ICD-10 Finland

Subjective visual disturbances

2.8

34.5

179

667

XF400

NOMESCO Finland

ECG with 12 standard connections

2.3

34.0

303

1458

Z01.8

ICD-10 Finland

Other specified special examinations

2.0

34.0

496

2874

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

8.4

33.0

R02

ICPC

Shortness of breath/dyspnoea

2.3

32.4

265

1228

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

3.5

32.3

115

343

UJF32

NOMESCO Finland

Coloscopy

1.9

32.2

480

2794

Z3231

NOMESCO Finland

Registered nurse

1.9

31.7

548

3346

R21

ICPC

Throat symptom/complaint

1.9

31.6

551

3373

N03AX15

ATC

zonisamide; oral

12.6

31.5

N02BF02

ATC

pregabalin; oral

2.9

31.5

160

589

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

31.3

1067

7923

R05

ICPC

Cough

1.9

31.0

523

3164

PA6AD

NOMESCO Finland

CT of neck arteries

4.3

30.8

199

ZX114

NOMESCO Finland

Intramuscular

5.7

30.7

105

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.1

30.5

313

1591

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.7

30.2

1212

9371

J01MA02

ATC

ciprofloxacin; systemic

1.8

30.1

726

4883

J01FA10

ATC

azithromycin; systemic

1.7

30.1

1299

10242

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

30.0

1151

8784

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.8

30.0

542

3347

H01

ICPC

Ear pain/earache

2.2

29.9

289

1433

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

29.9

445

2582

R07.3

ICD-10 Finland

Other chest pain

2.4

29.7

233

1059

R4110

NOMESCO Finland

Physiotherapy

1.8

29.4

543

3373

R55

ICD-10 Finland

Syncope and collapse

2.5

29.4

205

884

R03BB04

ATC

tiotropium bromide; inhalant

2.6

29.1

183

751

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

29.0

903

6499

Z3226

NOMESCO Finland

Physiotherapist

2.0

28.8

373

2061

N06AX12

ATC

bupropion; oral

2.3

28.8

231

1060

N06AX26

ATC

vortioxetine; oral

2.4

28.6

221

997

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.8

28.6

148

550

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.5

28.5

183

759

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.1

28.5

318

1666

A06AC01

ATC

ispaghula (psylla seeds); oral

1.9

28.4

476

2865

D06

ICPC

Abdominal pain localized other

2.4

28.0

209

929

M01AH01

ATC

celecoxib; oral

2.0

27.8

343

1861

J01FA06

ATC

roxithromycin; oral

1.7

27.5

816

5772

J01DB01

ATC

cefalexin; oral

2.0

27.5

1732

15018

N05CF02

ATC

zolpidem; oral

1.9

27.2

394

2258

G81.9

ICD-10 Finland

Hemiplegia, unspecified

6.9

27.2

XA800

NOMESCO Finland

Neuropsychological investigation

3.0

27.1

122

420

XCK00

NOMESCO Finland

Perimetry

3.1

26.7

116

391

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.3

26.2

204

923

A04

ICPC

Weakness/tiredness general

2.0

26.2

310

1656

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.3

26.1

210

963

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

26.0

679

4626

N05AB04

ATC

prochlorperazine; systemic, rectal

5.3

26.0

103

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.2

26.0

105

339

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

3.7

25.9

235

SAA01

NOMESCO Finland

Simple examination of mouth

1.8

25.9

1569

13274

R01AD09

ATC

mometasone; nasal

1.6

25.8

1017

7697

SPAT1060

SPAT

Administration of oxygen

24.4

25.7

N17

ICPC

Vertigo/dizziness

2.2

25.6

228

1091

Z71.8

ICD-10 Finland

Other specified counselling

1.7

25.5

680

4654

WX110

NOMESCO Finland

Infiltration anesthesia

1.7

25.4

1521

12780

K30

ICD-10 Finland

Functional dyspepsia

2.1

25.1

259

1314

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

4.8

24.8

119

F51.0

ICD-10 Finland

Nonorganic insomnia

1.8

24.8

408

2429

Z2445

NOMESCO Finland

Psychologist

2.9

24.7

123

447

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

3.7

24.6

220

G47.3

ICD-10 Finland

Sleep apnoea

1.8

24.6

476

2977

M54.3

ICD-10 Finland

Sciatica

2.6

24.4

143

566

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.7

24.0

131

500

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.0

23.8

105

357

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.8

23.8

119

434

J02AC01

ATC

fluconazole; systemic

1.6

23.7

845

6197

L17

ICPC

Foot/toe symptom/complaint

1.7

23.7

549

3606

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

23.7

742

5273

M54.6

ICD-10 Finland

Pain in thoracic spine

2.3

23.6

199

930

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

2.0

23.6

284

1522

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.5

23.6

152

630

R74

ICPC

Upper respiratory infection acute

1.6

23.5

786

5672

D11

ICPC

Diarrhoea

2.0

23.4

295

1608

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.6

23.3

140

561

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.6

23.3

214

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.1

23.2

259

1350

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

23.2

227

1127

N03AF02

ATC

oxcarbazepine; oral

3.2

23.2

299

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

23.0

367

2159

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

3.9

22.9

179

SPAT1254

SPAT

Administration of medicine

2.0

22.9

270

1436

R01AD58

ATC

fluticasone, combinations; nasal

1.7

22.9

601

4075

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.1

22.8

221

1092

J45.1

ICD-10 Finland

Nonallergic asthma

2.5

22.7

155

661

S06.0

ICD-10 Finland

Concussion

2.1

22.6

240

1229

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

3.3

22.6

278

R11

ICD-10 Finland

Nausea and vomiting

2.3

22.4

189

884

G54.0

ICD-10 Finland

Brachial plexus disorders

3.1

22.3

306

KH1AD

NOMESCO Finland

CT of urinary organs

3.3

22.3

270

G44.4

ICD-10 Finland

Drug-induced headache, not elsewhere classified

27.6

22.3

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

3.0

22.2

103

360

P01

ICPC

Feeling anxious/nervous/tense

1.9

22.2

338

1958

A03

ICPC

Fever

1.8

22.1

416

2570

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

22.1

665

4660

SPAT1050

SPAT

Extensive neurological examination

4.2

22.0

140

R01AD08

ATC

fluticasone; nasal

1.6

21.9

639

4440

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.0

21.9

272

1473

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.7

21.8

485

3139

Z00.0

ICD-10 Finland

General medical examination

1.8

21.8

387

2351

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.9

21.7

291

1617

F43.1

ICD-10 Finland

Post-traumatic stress disorder

3.0

21.6

328

N07BA03

ATC

varenicline; oral

2.6

21.6

133

540

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

21.5

610

4206

J01.1

ICD-10 Finland

Acute frontal sinusitis

4.0

21.4

156

J01DA01

ATC

[U] cefalexin

1.6

21.4

1251

10206

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

4.7

21.3

106

R06AE07

ATC

cetirizine; oral

1.6

21.3

942

7212

WX290

NOMESCO Finland

Other blockage of nerve

1.6

21.3

1098

8702

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.4

21.2

150

649

N06AB06

ATC

sertraline; oral

1.9

21.2

283

1570

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

21.1

588

4033

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

21.1

385

2355

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

21.1

274

1506

A06AD11

ATC

lactulose; oral

2.1

20.9

221

1128

M54.1

ICD-10 Finland

Radiculopathy

2.9

20.9

102

367

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

20.7

237

1245

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

20.7

565

3852

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.3

20.6

247

R03BA05

ATC

fluticasone; inhalant

1.8

20.6

384

2363

R1250

NOMESCO Finland

Evaluation of functional capability

3.8

20.5

170

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.1

20.5

217

1108

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

20.5

278

1549

R96

ICPC

Asthma

2.2

20.5

192

936

N05BA12

ATC

alprazolam; oral

2.1

20.5

215

1095

SAA04

NOMESCO Finland

Special examination of mouth

2.5

20.5

135

566

M89.0

ICD-10 Finland

Algoneurodystrophy

5.4

20.5

P76

ICPC

Depressive disorder

2.2

20.4

187

904

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.0

20.4

247

1325

N30.0

ICD-10 Finland

Acute cystitis

1.9

20.4

308

1778

R50.9

ICD-10 Finland

Fever, unspecified

1.9

20.3

306

1765

XF402

NOMESCO Finland

ECG with work load test

2.2

20.3

176

832

M70.6

ICD-10 Finland

Trochanteric bursitis

2.0

20.2

239

1271

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.6

20.1

196

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

20.1

396

2473

H53.2

ICD-10 Finland

Diplopia

3.2

20.0

262

L28

ICPC

Limited function/disability (L)

1.9

19.9

260

1429

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

19.9

696

5028

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

19.9

726

5296

M01AE01

ATC

ibuprofen; systemic, rectal

2.2

19.9

1913

17600

R4120

NOMESCO Finland

Occupational therapy

2.4

19.9

145

636

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

4.6

19.9

104

WX002

NOMESCO Finland

Sedation and analgesia

1.8

19.8

340

2039

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.1

19.7

203

1025

S18

ICPC

Laceration/cut

1.6

19.7

811

6075

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.8

19.7

362

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

19.6

455

2969

X58

ICD-10 Finland

Exposure to other specified factors

1.8

19.6

322

1905

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.9

19.6

255

1400

N06AA12

ATC

doxepin; systemic

2.7

19.6

106

403

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.8

19.6

103

386

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

7.8

19.6

N04BC05

ATC

pramipexole; oral

2.4

19.5

142

622

R03BA01

ATC

beclometasone; inhalant

1.9

19.5

274

1543

K08.80

ICD-10 Finland

Toothache NOS

2.0

19.4

227

1201

R05

ICD-10 Finland

Cough

1.7

19.4

417

2665

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

19.3

222

1167

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.4

19.3

143

632

N06AB03

ATC

fluoxetine; oral

1.9

19.3

269

1512

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.9

19.1

261

1456

SPAT1255

SPAT

Intravenous administration of medicine

2.4

19.1

130

553

N06AX22

ATC

agomelatine; oral

3.1

19.1

259

Z01.2

ICD-10 Finland

Dental examination

1.5

19.0

959

7494

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

18.9

275

1566

G90.2

ICD-10 Finland

Horner syndrome

16.0

18.8

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.5

18.8

122

508

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.9

18.7

316

ZXA10

NOMESCO Finland

Bilateral

1.8

18.7

306

1808

ABD99

NOMESCO Finland

Other operation on spinal cord or nerve for pain or impaired function

23.9

18.6

L02

ICPC

Back symptom/complaint

1.9

18.6

236

1284

M50.3

ICD-10 Finland

Other cervical disc degeneration

3.7

18.6

163

ZXA05

NOMESCO Finland

Left side

1.7

18.6

396

2523

K02.1

ICD-10 Finland

Caries of dentine

1.5

18.4

1281

10680

Z2446

NOMESCO Finland

Social worker

2.3

18.4

150

690

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

18.4

490

3305

D02

ICPC

Abdominal pain epigastric

2.3

18.4

139

619

R25.2

ICD-10 Finland

Cramp and spasm

3.6

18.4

174

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.9

18.3

303

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.3

18.2

137

609

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

18.2

849

6504

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

18.1

188

952

XKD00

NOMESCO Finland

Uroflowmetry

2.0

18.0

207

1089

R01AD12

ATC

fluticasone furoate; nasal

1.5

17.9

722

5357

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

3.4

17.8

197

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

17.7

369

2332

M48.0

ICD-10 Finland

Spinal stenosis

2.1

17.7

178

890

H92.0

ICD-10 Finland

Otalgia

2.2

17.7

148

688

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.3

17.6

133

592

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.0

17.6

202

1061

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.4

17.4

117

495

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.3

17.4

143

661

ZXE00

NOMESCO Finland

One hour or less

1.5

17.3

739

5539

SBB10

NOMESCO Finland

Dental impressions

2.2

17.3

160

775

N80.0

ICD-10 Finland

Endometriosis of uterus

3.4

17.3

186

SPAT1104

SPAT

Monitoring of emergency patient

2.4

17.2

125

547

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.0

17.1

184

944

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

4.0

17.0

122

F32.1

ICD-10 Finland

Moderate depressive episode

2.1

16.9

170

850

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

3.3

16.9

199

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

3.9

16.8

132

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.5

16.8

109

453

SPAT1283

SPAT

Restricted health certificate

1.6

16.8

457

3092

L12

ICPC

Hand/finger symptom/complaint

1.7

16.7

327

2031

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.5

16.6

102

413

J01FA09

ATC

clarithromycin; systemic

1.5

16.6

644

4720

3468X

ICD-9 Finland

Migraine, Other forms of migraine

90.8

16.6

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

2.4

16.6

120

525

SFA10

NOMESCO Finland

One-surface restoration

1.5

16.5

1150

9493

R06AX22

ATC

ebastine; oral

1.7

16.4

380

2466

R52.1

ICD-10 Finland

Chronic intractable pain

5.0

16.4

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

6.2

16.4

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.3

16.4

124

553

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.3

16.4

123

547

R07.0

ICD-10 Finland

Pain in throat

2.1

16.4

171

868

M01AH02

ATC

rofecoxib; oral

1.9

16.4

202

1088

N06AX03

ATC

mianserin; oral

2.6

16.3

393

M01AC06

ATC

meloxicam; systemic, rectal

1.5

16.2

646

4757

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

3.2

16.2

199

R10.0

ICD-10 Finland

Acute abdomen

2.8

16.2

296

P03

ICPC

Feeling depressed

1.8

16.0

249

1444

R03AC03

ATC

terbutaline; inhalant

1.8

16.0

284

1714

AA1AA

NOMESCO Finland

Head X-ray examination

6.2

15.9

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.5

15.9

104

434

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.7

15.9

316

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.3

15.9

127

580

M01AB55

ATC

diclofenac, combinations; oral

2.4

15.9

110

472

U07

ICPC

Urine symptom/complaint other

2.3

15.8

126

574

J45

ICD-10 Finland

Asthma

1.9

15.8

219

1225

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.0

15.8

192

1029

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.0

15.7

187

994

C01CA24

ATC

epinephrine; parenteral

2.0

15.7

167

853

P06

ICPC

Sleep disturbance

1.8

15.7

258

1522

M77.1

ICD-10 Finland

Lateral epicondylitis

1.9

15.7

199

1082

SPAT1263

SPAT

Sampling

1.5

15.6

794

6135

B02AA02

ATC

tranexamic acid; systemic

1.7

15.6

308

1913

C07AB12

ATC

nebivolol; oral

3.0

15.6

241

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

15.6

499

3499

K04.0

ICD-10 Finland

Pulpitis

1.8

15.5

240

1389

M02AA07

ATC

piroxicam; topical

1.5

15.5

593

4321

L08

ICPC

Shoulder symptom/complaint

1.6

15.4

392

2602

XF600

NOMESCO Finland

Bloodpressure measurement

2.3

15.4

118

529

K10.3

ICD-10 Finland

Alveolitis of jaws

2.2

15.4

126

581

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.7

15.4

281

1709

ZY010

NOMESCO Finland

Hospital outpatient

2.2

15.3

134

635

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

3.3

15.2

181

UKC02

NOMESCO Finland

Cystoscopy

1.8

15.2

222

1263

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.6

15.2

347

A02BA04

ATC

nizatidine; systemic

2.3

15.1

120

546

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

15.1

586

4279

N30.9

ICD-10 Finland

Cystitis, unspecified

2.3

15.1

116

521

Z3229

NOMESCO Finland

Other healthcare associate professional

2.1

15.1

143

700

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

3.6

15.0

143

M01AX17

ATC

nimesulide; oral

1.6

15.0

377

2493

S22.3

ICD-10 Finland

Fracture of rib

2.1

15.0

138

668

J01EA01

ATC

trimethoprim; systemic

1.6

14.9

445

3065

UJF30

NOMESCO Finland

Ileoscopy through colon

1.9

14.8

192

1050

N05CD07

ATC

temazepam; oral

2.0

14.7

163

845

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.3

14.7

165

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.3

14.7

165

C10AC01

ATC

colestyramine; oral

3.1

14.7

201

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.9

14.6

205

1150

SPAT1240

SPAT

Therapeutic discussion

1.8

14.6

260

1569

SPAT1301

SPAT

No procedures

1.5

14.6

531

3822

R60.9

ICD-10 Finland

Oedema, unspecified

2.4

14.5

403

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.4

14.5

403

WX402

NOMESCO Finland

General anaesthesia

1.6

14.5

412

2805

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.0

14.5

170

899

J39.9

ICD-10 Finland

Disease of upper respiratory tract, unspecified

6.6

14.5

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

14.5

268

1635

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

3.5

14.5

142

S01EC01

ATC

acetazolamide; systemic

3.8

14.4

114

J46

ICD-10 Finland

Status asthmaticus

3.0

14.3

225

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

14.3

473

3331

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

14.3

197

1100

J01DA06

ATC

[U] cefuroxime

1.7

14.2

284

1768

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

14.2

384

2582

N02CD05

ATC

eptinezumab; parenteral

42.8

14.1

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

4.0

14.1

XF404

NOMESCO Finland

Ambulatory ECG

2.1

14.0

139

692

J01MA14

ATC

moxifloxacin; systemic

2.0

14.0

164

867

G04CA02

ATC

tamsulosin; oral

1.7

13.9

279

1738

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.1

13.9

141

707

A03CA02

ATC

clidinium and psycholeptics; oral

2.4

13.9

387

A29

ICPC

General symptom/complaint other

1.8

13.8

211

1216

79199

ICD-8 Finland

Headache

4.9

13.8

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

6.3

13.7

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

13.6

254

1551

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.4

13.6

143

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.9

13.6

170

919

A28

ICPC

Limited function/disability NOS

1.9

13.6

194

1095

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.7

13.6

266

1647

K80

ICPC

Cardiac arrhythmia NOS

2.0

13.6

141

714

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.9

13.5

178

978

G47.9

ICD-10 Finland

Sleep disorder, unspecified

2.7

13.5

261

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.5

13.4

362

U01

ICPC

Dysuria/painful urination

2.0

13.4

150

781

R12

ICD-10 Finland

Heartburn

1.9

13.3

165

890

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.1

13.2

123

597

R83

ICPC

Respiratory infection other

1.5

13.2

600

4504

Z2221

NOMESCO Finland

Medical doctor

1.5

13.2

516

3759

TAB20

NOMESCO Finland

Epidural puncture

5.5

13.1

R13

ICD-10 Finland

Dysphagia

2.1

13.1

125

614

R63.4

ICD-10 Finland

Abnormal weight loss

2.7

13.0

260

R06AX27

ATC

desloratadine; oral

1.5

13.0

626

4750

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

2.0

13.0

143

740

R00.2

ICD-10 Finland

Palpitations

1.9

12.9

167

913

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.2

12.9

111

523

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.8

12.8

202

1175

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.5

12.8

129

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.0

12.7

143

745

A02BA03

ATC

famotidine; systemic

3.0

12.7

191

K11.2

ICD-10 Finland

Sialoadenitis

2.6

12.7

281

A99

ICPC

Disease/condition unspecnature/site

1.9

12.7

165

903

R09

ICPC

Sinus symptom/complaint

1.8

12.7

195

1126

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.8

12.7

230

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.9

12.6

176

985

R60.0

ICD-10 Finland

Localized oedema

1.8

12.6

184

1045

G03DC03

ATC

lynestrenol; oral

3.0

12.6

192

N95

ICPC

Tension headache

6.0

12.6

R03BA02

ATC

budesonide; inhalant

1.6

12.6

350

2365

S29

ICPC

Skin symptom/complaint other

1.6

12.6

331

2208

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.8

12.5

213

1266

L86

ICPC

Back syndrome with radiating pain

2.1

12.5

118

576

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.8

12.5

226

J01MA12

ATC

levofloxacin; systemic

1.6

12.5

289

1867

B01AB05

ATC

enoxaparin; parenteral

1.5

12.5

499

3646

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.5

12.4

530

3921

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.8

12.4

201

1178

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.7

12.4

249

1550

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.8

12.4

197

1148

N06AX05

ATC

trazodone; oral

2.7

12.4

244

N03

ICPC

Pain face

4.7

12.4

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

12.4

730

5738

L50.9

ICD-10 Finland

Urticaria, unspecified

2.4

12.3

383

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

12.3

536

3979

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

12.3

140

733

F43.00

ICD-10 Finland

Acute stress reaction mild

2.6

12.3

286

J20

ICD-10 Finland

Acute bronchitis

1.8

12.3

199

1167

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

12.2

461

3325

K59.09

ICD-10 Finland

Constipation, unspecified

2.2

12.2

103

481

AA1CG, ,

SPAT

4.3

12.2

WYA10

NOMESCO Finland

Emergency care or similar visit

1.9

12.2

160

879

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

12.2

1402

12346

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.1

12.2

122

610

XQ800

NOMESCO Finland

Prick test

1.8

12.1

175

991

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.7

12.1

238

1474

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.5

12.0

325

SPAT1260

SPAT

Consultation of another employee

1.6

12.0

300

1974

J01CA04

ATC

amoxicillin; systemic

1.5

12.0

1666

15176

P29

ICPC

Psychological sympt/compl other

1.8

12.0

175

994

UJH02

NOMESCO Finland

Anoscopy

2.4

12.0

338

WX892

NOMESCO Finland

Monitored bed care

2.0

11.9

127

649

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

11.9

119

594

F61.0

ICD-10 Finland

Mixed personality disorders

3.1

11.9

166

KMAK, ,

NOMESCO Finland

1.4

11.9

1073

9047

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.1

11.8

113

555

SPAT1252

SPAT

Overall medication plan or its review

2.2

11.8

442

C07AB03

ATC

atenolol; systemic

2.5

11.8

310

Z50.1

ICD-10 Finland

Other physical therapy

2.3

11.8

423

A01AB09

ATC

miconazole; local oral

1.9

11.8

142

758

PA6AG

NOMESCO Finland

Limited MRI examination of neck vasculature with high intensity magnet

5.2

11.7

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.8

11.7

182

1053

A07AA02

ATC

nystatin; oral

2.2

11.7

424

L29

ICPC

Musculoskeletal sympt/complt other

1.9

11.6

154

848

R06.2

ICD-10 Finland

Wheezing

2.2

11.6

426

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.0

11.6

128

663

SFA20

NOMESCO Finland

Two-surface restoration

1.4

11.6

1213

10463

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

11.6

424

3038

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.7

11.6

230

R03AC12

ATC

salmeterol; inhalant

2.5

11.5

307

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

3.2

11.5

138

ZXD05

NOMESCO Finland

Urgent procedure

1.4

11.5

567

4302

ZXD35

NOMESCO Finland

Usual procedure

2.6

11.5

248

SPAT1097

SPAT

Recording of ECG

1.7

11.5

213

1298

SPAT1312

SPAT

General health counselling

1.4

11.4

582

4441

D09

ICPC

Nausea

2.1

11.4

106

515

L15

ICPC

Knee symptom/complaint

1.5

11.4

403

2864

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

3.0

11.4

165

L04

ICPC

Chest symptom/complaint

2.0

11.4

123

632

M01AE51

ATC

ibuprofen, combinations; systemic

3.9

11.4

R05FB02

ATC

cough suppressants and expectorants; systemic

1.4

11.4

610

4699

C10AA05

ATC

atorvastatin; oral

1.4

11.3

563

4276

M54

ICD-10 Finland

Dorsalgia

1.6

11.3

263

1699

N02CA72

ATC

ergotamine, combinations with psycholeptics; oral

15.1

11.3

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.7

11.3

219

1350

F01

ICPC

Eye pain

2.6

11.3

268

J45.8

ICD-10 Finland

Mixed asthma

2.6

11.3

239

AA1BG, ,

SPAT

3.0

11.3

161

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.8

11.2

190

1128

N02AJ13

ATC

tramadol and paracetamol; systemic

3.0

11.2

172

K04.00

ICD-10 Finland

Hyperemia of pulp

2.0

11.2

117

594

T78.4

ICD-10 Finland

Allergy, unspecified

2.1

11.2

106

519

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.6

11.2

262

1696

L05

ICPC

Flank/axilla symptom/complaint

2.1

11.2

113

567

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

11.2

129

679

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.7

11.1

213

1308

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.9

11.1

140

759

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

11.1

375

2640

C01DA14

ATC

isosorbide mononitrate; oral

1.9

11.1

135

724

N07CA01

ATC

betahistine; oral

2.1

11.0

110

549

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.2

10.9

450

R03AC13

ATC

formoterol; inhalant

2.2

10.9

424

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

3.0

10.9

159

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.1

10.9

471

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

8.3

10.8

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.7

10.8

228

1438

L29.9

ICD-10 Finland

Pruritus, unspecified

2.6

10.7

233

K04

ICPC

Palpitations/awareness of heart

2.1

10.7

480

G44.3

ICD-10 Finland

Chronic post-traumatic headache

17.9

10.7

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.8

10.7

188

OAB93, ,

SPAT

1.8

10.7

157

894

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.6

10.7

228

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

2.4

10.7

325

SFA30

NOMESCO Finland

Three-surface restoration

1.4

10.6

805

6554

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.9

10.6

141

778

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

2.6

10.6

247

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.7

10.5

195

1187

SPAT1153

SPAT

Removal of sutures

1.4

10.5

491

3679

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

10.5

496

3724

M01AX01

ATC

nabumetone; oral

2.4

10.5

296

PA2AD

NOMESCO Finland

CT angiography of brain

4.5

10.5

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

2.6

10.5

236

M22.4

ICD-10 Finland

Chondromalacia patellae

2.3

10.4

348

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.7

10.4

200

1231

B01AC04

ATC

clopidogrel; oral

1.7

10.3

182

1093

K59.01

ICD-10 Finland

Constipation outlet obstruction type

3.8

10.3

XA402

NOMESCO Finland

ENMG

2.7

10.3

209

N06BA04

ATC

methylphenidate; oral

2.1

10.3

448

R01

ICPC

Pain respiratory system

2.9

10.3

159

S80.0

ICD-10 Finland

Contusion of knee

1.8

10.3

155

890

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

4.6

10.2

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.3

10.2

350

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.7

10.2

218

1377

A04AA01

ATC

ondansetron; systemic, rectal

1.9

10.2

135

743

ZXD20

NOMESCO Finland

Day surgery

1.6

10.2

231

1481

J01DC02

ATC

cefuroxime; systemic

2.0

10.2

117

614

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.3

10.2

351

H02.4

ICD-10 Finland

Ptosis of eyelid

2.7

10.2

199

J01DA09

ATC

[U] cefadroxil

1.4

10.1

503

3808

K59.1

ICD-10 Finland

Functional diarrhoea

2.0

10.1

102

512

R75

ICPC

Sinusitis acute/chronic

2.0

10.1

109

561

D10

ICPC

Vomiting

1.8

10.1

143

806

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.7

10.0

195

1204

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

10.0

191

1173

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.0

10.0

113

591

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

10.0

420

3084

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

2.1

10.0

420

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.3

9.9

310

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.7

9.9

190

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

9.9

191

1176

R03BA08

ATC

ciclesonide; inhalant

1.7

9.9

173

1037

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

9.9

534

4102

XKC03

NOMESCO Finland

Water cystometry

2.7

9.9

185

N94.5

ICD-10 Finland

Secondary dysmenorrhoea

2.7

9.8

191

H15.1

ICD-10 Finland

Episcleritis

3.1

9.8

131

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.0

9.8

111

581

J01

ICD-10 Finland

Acute sinusitis

1.9

9.8

125

681

L16

ICPC

Ankle symptom/complaint

1.6

9.7

216

1380

SPAT1058

SPAT

PEF monitoring instruction

1.9

9.7

128

705

J31.0

ICD-10 Finland

Chronic rhinitis

1.7

9.7

172

1035

F41.00

ICD-10 Finland

Moderate panic disorder

2.8

9.6

176

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.2

9.6

353

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.4

9.6

277

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.9

9.6

119

642

C08CA05

ATC

nifedipine; systemic

2.2

9.6

393

J01CA08

ATC

pivmecillinam; oral

1.4

9.6

719

5822

SGA01

NOMESCO Finland

Emergency treatment

1.5

9.6

362

2601

R01AD11

ATC

triamcinolone; nasal

1.7

9.5

164

978

G93.3

ICD-10 Finland

Postviral fatigue syndrome

4.8

9.5

U02

ICPC

Urinary frequency/urgency

1.6

9.5

227

1474

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

9.5

800

6591

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.7

9.5

183

K60.2

ICD-10 Finland

Anal fissure, unspecified

3.0

9.5

139

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

3.3

9.5

108

K04.08

ICD-10 Finland

Other specified pulpit

1.7

9.4

187

1160

L13

ICPC

Hip symptom/complaint

1.6

9.4

258

1732

M01AG01

ATC

mefenamic acid; oral

2.5

9.3

244

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

9.3

162

969

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

3.0

9.3

135

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

2.0

9.3

500

N06AX17

ATC

milnacipran; oral

3.7

9.3

C08DB01

ATC

diltiazem; oral

2.6

9.3

197

JAH01

NOMESCO Finland

Laparoscopy

2.0

9.3

473

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.7

9.3

156

925

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

9.2

251

1681

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.8

9.2

129

724

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

3.2

9.2

115

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.0

9.2

502

R30.0

ICD-10 Finland

Dysuria

2.1

9.2

420

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.9

9.2

123

681

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.9

9.2

119

652

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.8

9.2

151

890

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.2

9.2

328

Z01.7

ICD-10 Finland

Laboratory examination

1.5

9.1

265

1802

P25

ICPC

Phase of life problem adult

2.0

9.1

100

518

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.3

9.1

316

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.8

9.1

146

854

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.6

9.1

205

R29

ICPC

Respiratory symptom/complaint other

1.8

9.1

128

720

E22.1

ICD-10 Finland

Hyperprolactinaemia

3.8

9.1

R35

ICD-10 Finland

Polyuria

2.0

9.1

103

540

M76.0

ICD-10 Finland

Gluteal tendinitis

2.6

9.0

188

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.9

9.0

114

619

K04.09

ICD-10 Finland

Pulpit UNS

1.9

9.0

108

576

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.0

9.0

464

N06AA06

ATC

trimipramine; systemic

2.6

9.0

194

Z01.9

ICD-10 Finland

Special examination, unspecified

2.0

9.0

103

541

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

2.3

9.0

311

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.7

9.0

161

971

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.9

9.0

115

628

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.6

9.0

190

1199

S90.3

ICD-10 Finland

Contusion of other and unspecified parts of foot

2.3

8.9

280

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.1

8.9

411

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.8

8.9

137

791

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.8

8.9

131

747

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.9

8.9

120

666

J01FA15

ATC

telithromycin; oral

1.6

8.9

189

1194

N05AA02

ATC

levomepromazine; systemic

2.1

8.8

386

Z71.9

ICD-10 Finland

Counselling, unspecified

1.8

8.8

136

786

M54.8

ICD-10 Finland

Other dorsalgia

2.0

8.8

434

N05AH03

ATC

olanzapine; systemic

1.8

8.8

138

802

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

3.8

8.8

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

8.8

198

1269

EBA00

NOMESCO Finland

Extraction of tooth

1.3

8.8

675

5471

EMB10

NOMESCO Finland

Tonsillectomy

1.8

8.8

138

803

A62

ICPC

General and Unspecified, Administrative procedure

2.7

8.7

174

Z72.0

ICD-10 Finland

Tobacco use

2.4

8.7

246

SPAT1229

SPAT

Assessment of need for aid

2.0

8.7

492

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.5

8.7

216

DHB50

NOMESCO Finland

Turbinoplasty

2.3

8.6

278

WX400

NOMESCO Finland

Inhalation anesthesy

2.1

8.6

403

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.9

8.6

101

535

D07AD01

ATC

clobetasol; topical

1.5

8.6

277

1923

E0000UV, ,

ATC

1.3

8.6

756

6242

N81.6

ICD-10 Finland

Rectocele

2.0

8.6

500

R01AD01

ATC

beclometasone; nasal

1.5

8.6

294

2067

WX702

NOMESCO Finland

Supraglottic ventilation device

1.9

8.6

104

557

H02AB09

ATC

hydrocortisone; systemic

2.6

8.6

193

SPF12

NOMESCO Finland

Fitting of the denture in the mouth during the repair of the loose prosthesis

4.8

8.6

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.8

8.6

136

793

H02BX01

ATC

methylprednisolone, combinations; systemic

2.3

8.6

273

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.6

8.5

189

1205

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.7

8.5

143

847

DFF00

NOMESCO Finland

Pure tone audiometry

1.7

8.5

149

893

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.5

8.5

I20.09

ICD-10 Finland

Unstable angina

2.2

8.5

325

P74

ICPC

Anxiety disorder/anxiety state

1.9

8.5

109

595

M01AB08

ATC

etodolac; oral

1.8

8.5

120

676

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.1

8.5

406

A02BC04

ATC

rabeprazole; oral

1.7

8.4

167

1035

AAW01

NOMESCO Finland

Implantation of intracranial stimulation device

90.4

8.4

M53.3

ICD-10 Finland

Sacrococcygeal disorders, not elsewhere classified

3.1

8.4

111

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

8.4

682

5565

L60.0

ICD-10 Finland

Ingrowing nail

2.0

8.4

463

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.7

8.4

159

975

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

3.4

8.4

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.5

8.3

214

J35.0

ICD-10 Finland

Chronic tonsillitis

1.8

8.3

126

725

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

2.0

8.3

416

G01AF05

ATC

econazole; vaginal

1.7

8.3

145

870

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

8.3

118

667

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

8.3

262

1814

R31

ICD-10 Finland

Unspecified haematuria

1.8

8.3

127

734

SPAT1216

SPAT

Assessment of functional ability

1.6

8.2

188

1208

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

8.2

103

558

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.9

8.2

508

R01AD05

ATC

budesonide; nasal

1.7

8.2

145

871

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.8

8.2

119

675

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.9

8.2

102

551

-1, ,

NOMESCO Finland

1.3

8.2

661

5380

DE2CG

NOMESCO Finland

Acoustic channel extensive MRI examination with high intensity magnet

3.4

8.2

A01AB04

ATC

amphotericin B; local oral

2.2

8.2

298

EB1VA, ,

NOMESCO Finland

1.5

8.2

236

1602

R03AK08

ATC

formoterol and beclometasone; inhalant

2.0

8.1

426

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

3.1

8.1

108

H03AA01

ATC

levothyroxine sodium; systemic

1.4

8.1

381

2843

K04.1

ICD-10 Finland

Necrosis of pulp

1.6

8.1

213

1414

H93.1

ICD-10 Finland

Tinnitus

1.8

8.1

122

700

SGC10

NOMESCO Finland

Pulp capping

1.6

8.1

203

1333

F03

ICPC

Eye discharge

1.8

8.1

122

701

N76.0

ICD-10 Finland

Acute vaginitis

1.7

8.1

147

891

119

Kela drug reimbursment

Trigeminal neuralgia or glossofaryngeusneuralgia

8.2

8.1

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.9

8.1

512

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

8.1

128

747

C03CA01

ATC

furosemide; systemic

1.5

8.1

292

2077

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

8.0

105

577

N02AC04

ATC

dextropropoxyphene; oral

2.5

8.0

188

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

2.9

8.0

131

L20

ICPC

Joint symptom/complaint NOS

2.2

8.0

321

WX704

NOMESCO Finland

Intubation

1.7

8.0

137

818

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

4.3

7.9

R39.1

ICD-10 Finland

Other difficulties with micturition

2.5

7.9

183

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

2.3

7.9

238

R04

ICPC

Breathing problem other

2.2

7.9

309

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

7.9

329

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.9

7.9

516

SPAT1360

SPAT

Extensive global examination

1.9

7.9

101

552

L10

ICPC

Elbow symptom/complaint

1.8

7.9

107

596

ZXA00

NOMESCO Finland

Right side

1.4

7.9

376

2815

N20.9

ICD-10 Finland

Urinary calculus, unspecified

2.5

7.8

196

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.5

7.8

190

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.0

7.8

439

TKC20

NOMESCO Finland

Catheterisation of bladder

2.0

7.8

447

C10AA07

ATC

rosuvastatin; oral

1.4

7.8

463

3594

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2.0

7.8

385

R33

ICD-10 Finland

Retention of urine

2.0

7.7

448

J02AC02

ATC

itraconazole; systemic

1.5

7.7

302

2179

R25.1

ICD-10 Finland

Tremor, unspecified

2.5

7.7

186

XJH00

NOMESCO Finland

Transanal ultrasonography

2.2

7.6

287

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.1

7.6

320

T74.1

ICD-10 Finland

Physical abuse

2.4

7.6

205

A97

ICPC

No disease

1.5

7.6

292

2099

K29.7

ICD-10 Finland

Gastritis, unspecified

2.2

7.6

268

R4110, ,

SPAT

1.7

7.6

130

775

H04.5

ICD-10 Finland

Stenosis and insufficiency of lacrimal passages

2.8

7.6

129

R52.0

ICD-10 Finland

Acute pain

2.1

7.6

341

K07.58

ICD-10 Finland

Other abnormal function of teeth and jaws

3.6

7.6

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

3.2

7.5

N04BC09

ATC

rotigotine; transdermal

8.9

7.5

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.5

7.5

194

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.7

7.5

129

770

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

7.5

124

732

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

2.0

7.5

397

A06AC51

ATC

ispaghula, combinations; oral

2.0

7.5

391

B34.9

ICD-10 Finland

Viral infection, unspecified

2.2

7.4

297

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.7

7.4

142

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

2.1

7.4

351

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

2.0

7.4

365

AEA20

NOMESCO Finland

Removal of impulse generator of stimulation device in the nervous system

13.4

7.4

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.0

7.4

428

K92.1

ICD-10 Finland

Melaena

2.1

7.3

325

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

4.0

7.3

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

7.3

196

1307

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.6

7.3

163

1041

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

7.3

441

3426

DM1BD

NOMESCO Finland

Extensive CT of paranasal sinuses and face area

8.4

7.3

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.6

7.3

155

R518, ,

ICD-10 Finland

6.8

7.3

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.1

7.3

306

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

2.9

7.3

110

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.8

7.3

105

596

H57.0

ICD-10 Finland

Anomalies of pupillary function

4.2

7.3

N20.1

ICD-10 Finland

Calculus of ureter

2.2

7.3

293

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.2

7.3

267

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

3.8

7.3

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.8

7.2

105

597

L02.0

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of face

2.8

7.2

127

C10AX09

ATC

ezetimibe; oral

1.5

7.2

209

1419

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.1

7.2

314

NF1AA

NOMESCO Finland

Hip X-ray examination

1.8

7.2

101

569

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.7

7.2

127

765

M01AH03

ATC

valdecoxib; oral

1.8

7.2

540

O20.0

ICD-10 Finland

Threatened abortion

2.2

7.2

262

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

4.0

7.2

SPAT1106

SPAT

Acupuncture

4.0

7.2

L11

ICPC

Wrist symptom/complaint

1.6

7.1

166

1072

K58

ICD-10 Finland

Irritable bowel syndrome

2.2

7.1

256

SPAT1044

SPAT

Tympanometry

2.5

7.1

175

R06AE09

ATC

levocetirizine; oral

1.4

7.1

286

2074

N39.3

ICD-10 Finland

Stress incontinence

1.8

7.1

112

654

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.3

7.1

225

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.6

7.0

153

972

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.4

7.0

423

3284

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

2.3

7.0

232

SPF02

NOMESCO Finland

Impression for dental prosthesis repair, restricted

4.2

7.0

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.6

7.0

180

1190

R04.2

ICD-10 Finland

Haemoptysis

2.4

7.0

207

F41.8

ICD-10 Finland

Other specified anxiety disorders

2.0

7.0

373

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

3.4

7.0

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.0

7.0

387

K12.18

ICD-10 Finland

Other forms of stomatitis

4.4

7.0

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

7.0

106

612

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.7

6.9

123

741

M70.7

ICD-10 Finland

Other bursitis of hip

2.5

6.9

171

R07.2

ICD-10 Finland

Precordial pain

2.7

6.9

130

P02

ICPC

Acute stress reaction

1.7

6.9

122

734

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.4

6.9

202

OAA65, ,

SPAT

1.4

6.9

390

2997

N05AD01

ATC

haloperidol; systemic

2.4

6.9

196

M18.0

ICD-10 Finland

Primary arthrosis of first carpometacarpal joints, bilateral

3.1

6.9

E66.01

ICD-10 Finland

Obesity due to excess calories

1.5

6.9

184

1228

M13.9

ICD-10 Finland

Arthritis, unspecified

1.7

6.9

128

782

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.5

6.9

160

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.9

6.9

482

F32

ICD-10 Finland

Depressive episode

1.7

6.8

117

698

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.9

6.8

475

N06AB05

ATC

paroxetine; oral

1.7

6.8

115

683

H81.0

ICD-10 Finland

Ménière disease

2.7

6.8

131

R03DA04

ATC

theophylline; systemic, rectal

2.1

6.8

314

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.0

6.8

362

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.5

6.8

208

1428

N30.8

ICD-10 Finland

Other cystitis

3.8

6.8

G04BD12

ATC

mirabegron; oral

1.6

6.8

139

870

N92

ICPC

Trigeminal neuralgia

11.0

6.8

UJF92

NOMESCO Finland

Capsular endoscopy

2.4

6.8

179

PAW37

NOMESCO Finland

Biopsy of temporal artery

9.3

6.8

R49.08

ICD-10 Finland

Other specified dysphonia

2.5

6.8

173

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.5

6.8

155

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

2.7

6.7

132

R06.5

ICD-10 Finland

Mouth breathing

1.6

6.7

158

1023

F29

ICPC

Eye symptom/complaint other

1.6

6.7

155

999

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.6

6.7

144

S21

ICPC

Skin texture symptom/complaint

1.5

6.7

214

1483

N94.6

ICD-10 Finland

Dysmenorrhoea, unspecified

2.3

6.7

224

M79.9

ICD-10 Finland

Soft tissue disorder, unspecified

3.4

6.7

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.9

6.7

414

SPAT1310

SPAT

Counselling related to known health issue

1.3

6.7

536

4339

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.7

6.7

114

680

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.8

6.6

116

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.2

6.6

251

S16

ICPC

Bruise/contusion

2.3

6.6

206

M50.9

ICD-10 Finland

Cervical disc disorder, unspecified

4.0

6.6

H15.0

ICD-10 Finland

Scleritis

7.8

6.6

U05

ICPC

Urination problems other

2.0

6.6

325

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

6.6

209

1446

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.0

6.6

353

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

12.3

6.6

D07AC01

ATC

betamethasone; topical

1.3

6.6

606

4998

T14.0

ICD-10 Finland

Superficial injury of unspecified body region

3.2

6.6

K07.6

ICD-10 Finland

Temporomandibular joint disorders

3.5

6.6

H66.9

ICD-10 Finland

Otitis media, unspecified

1.7

6.6

127

784

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

2.4

6.6

182

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

6.5

178

1192

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.2

6.5

259

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

2.6

6.5

146

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

3.8

6.5

LCA06

NOMESCO Finland

Biopsy of endometrium

1.5

6.5

203

1399

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.5

6.5

152

K59.0

ICD-10 Finland

Constipation

1.9

6.5

425

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.5

6.5

222

1559

R06AX26

ATC

fexofenadine; oral

1.6

6.5

142

904

JEA00

NOMESCO Finland

Appendectomy

1.7

6.5

116

701

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.6

6.5

135

N80.9

ICD-10 Finland

Endometriosis, unspecified

2.2

6.5

234

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

2.0

6.5

321

K35.9

ICD-10 Finland

Acute appendicitis, unspecified

1.6

6.5

148

953

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.5

6.4

147

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

2.7

6.4

118

SFA00

NOMESCO Finland

Small restoration

1.4

6.4

245

1757

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

6.4

314

2354

R20.0

ICD-10 Finland

Anaesthesia of skin

3.5

6.4

M02AA10

ATC

ketoprofen; topical

1.5

6.4

234

1664

M41.9

ICD-10 Finland

Scoliosis, unspecified

3.2

6.4

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

3.4

6.4

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

3.3

6.4

NA1BG, ,

SPAT

2.4

6.4

184

3461A

ICD-9 Finland

Migraine, Common migraine

14.3

6.4

G02CB01

ATC

bromocriptine; systemic

2.4

6.4

178

SPAT1377

SPAT

Polysomnography

2.1

6.4

295

R08

ICPC

Nose symptom/complaint other

2.0

6.4

350

A03FA02

ATC

cisapride; oral, rectal

1.8

6.4

560

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.8

6.4

479

R04.0

ICD-10 Finland

Epistaxis

1.8

6.4

538

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.5

6.4

148

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

2.3

6.4

210

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

2.3

6.4

210

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

8.2

6.3

LCH00

NOMESCO Finland

Vacuum aspiration of products of conception from uterus

2.0

6.3

303

F45.0

ICD-10 Finland

Somatization disorder

5.2

6.3

R03AK11

ATC

formoterol and fluticasone; inhalant

2.2

6.3

217

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

2.2

6.3

243

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.0

6.3

352

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

6.3

318

2398

3460A

ICD-9 Finland

Migraine, Classical migraine

9.3

6.3

ZA6.0

ICD-10 Finland

Lower leg

3.3

6.3

C08CA06

ATC

nimodipine; systemic

18.1

6.3

G04BD08

ATC

solifenacin; oral

1.9

6.3

431

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

2.0

6.3

325

S01GX02

ATC

levocabastine; ophthalmic

1.7

6.3

111

670

P01BA02

ATC

hydroxychloroquine; oral

1.6

6.2

130

818

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.3

6.2

199

G51.8

ICD-10 Finland

Other disorders of facial nerve

26.8

6.2

K05.0

ICD-10 Finland

Acute gingivitis

2.2

6.2

238

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.1

6.2

278

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.5

6.2

144

A05

ICPC

Feeling ill

1.7

6.2

121

749

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.7

6.2

122

757

TPH07

NOMESCO Finland

Cathetrisation of artery

1.6

6.2

140

899

R03BC03

ATC

nedocromil; inhalant

1.7

6.2

108

649

M75.8

ICD-10 Finland

Other shoulder lesions

1.9

6.2

404

J32.1

ICD-10 Finland

Chronic frontal sinusitis

4.0

6.2

S63.5

ICD-10 Finland

Sprain and strain of wrist

1.9

6.2

426

L04AA13

ATC

[U] leflunomide

2.4

6.2

175

S00.0

ICD-10 Finland

Superficial injury of scalp

2.4

6.1

163

B01AA03

ATC

warfarin; systemic

1.5

6.1

175

1185

SBA00

NOMESCO Finland

Microbiological examinations

2.3

6.1

188

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.7

6.1

575

X15

ICPC

Vaginal symptom/complaint other

1.8

6.1

449

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.5

6.1

209

1469

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.7

6.1

104

621

N05BE01

ATC

buspirone; oral

2.1

6.1

287

C05AA08

ATC

fluocortolone; rectal, topical

1.5

6.1

205

1436

4211

FHL

Transeptal septal resection and reconstruction

4.1

6.1

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.5

6.1

222

1581

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.0

6.1

336

TNX00, ,

SPAT

2.9

6.1

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.9

6.1

S02.51

ICD-10 Finland

Fracture of tooth, open

1.5

6.0

169

1139

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.1

6.0

281

J34.1

ICD-10 Finland

Cyst and mucocele of nose and nasal sinus

2.6

6.0

134

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.2

6.0

228

L50.0

ICD-10 Finland

Allergic urticaria

2.1

6.0

268

R5110, ,

SPAT

1.8

6.0

466

P20

ICPC

Memory disturbance

1.7

6.0

106

639

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

3.3

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

779

4241

2.35

71.16

2.5

2.1

126.04

255.22

u/l

3.09

742

4027

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1072

6996

2.11

59.17

6.1

6.5

1.21

mmol/l

0.14

935

5978

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

975

6296

2.04

53.64

5.6

5.8

1.21

mmol/l

0.13

918

5802

(3013707) Erythrocyte sedimentation rate by Westergren method

1577

12182

2.26

53.01

4.8

3.8

9.25

9.98

mm/h

1.87

1499

11412

(3013826) Glucose [Moles/volume] in Serum or Plasma

1249

8923

2.02

50.49

5.6

4.6

6.24

6.54

mmol/l

7.90

1200

8252

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

667

3819

2.11

50.17

1.9

1.8

0.82

0.95

mg/l

0.65

489

2829

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

843

5324

1.99

47.80

3.9

3.0

26.41

45.77

ng/l

0.95

454

3064

(3036481) Cortisol [Moles/volume] in Serum or Plasma

345

1596

2.40

43.06

2.3

2.1

346.81

371.94

nmol/l

1.83

322

1484

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1542

12230

2.04

42.13

8.1

7.1

75.43

74.85

u/l

0.16

1483

11611

(3024561) Albumin [Mass/volume] in Serum or Plasma

919

6168

1.89

41.84

4.6

4.8

36.72

36.47

g/l

0.75

867

5791

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

767

4863

1.92

41.54

3.2

2.6

54.00

58.01

u/l

2.04

727

4527

(3037467) Urinalysis macro (dipstick) panel - Urine

1439

11208

1.95

40.53

4.9

3.8

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1364

10447

1.91

40.33

5.4

3.8

210.81

921.56

e6/l

1.16

123

(3018418) pH of Serum or Plasma

670

4115

1.93

39.52

3.4

3.9

7.39

7.40

0.94

131

817

(3013115) Eosinophils [#/volume] in Blood

1179

8719

1.83

37.88

5.9

6.2

0.19

e9/l

0.23

1069

7779

(3006315) Basophils [#/volume] in Blood

1148

8429

1.82

37.69

5.8

5.9

0.04

e9/l

0.05

1029

7397

(3019198) Lymphocytes [#/volume] in Blood

1176

8714

1.82

37.28

5.8

5.9

2.02

1.98

e9/l

0.53

1074

7836

(3001604) Monocytes [#/volume] in Blood

1144

8414

1.81

37.11

5.8

5.9

0.56

e9/l

0.24

1025

7397

(3006504) Eosinophils/100 leukocytes in Blood

1086

7887

1.80

36.53

5.9

6.0

2.75

2.83

0.60

1043

7428

(3002030) Lymphocytes/100 leukocytes in Blood

1122

8229

1.80

36.50

5.9

6.0

29.33

28.92

0.66

1078

7791

(3013650) Neutrophils [#/volume] in Blood by Automated count

1264

9606

1.82

36.48

8.1

8.9

4.10

4.01

e9/l

0.83

1139

8461

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

536

3123

1.97

36.46

1.4

1.3

25.29

26.61

iu/ml

0.10

165

998

(3019069) Monocytes/100 leukocytes in Blood

1091

7942

1.80

36.33

6.2

6.3

8.10

8.32

1.68

1047

7499

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1622

13356

2.02

36.28

4.9

4.0

14.51

14.50

pmol/l

0.07

1542

12431

(3018010) Neutrophils/100 leukocytes in Blood

1110

8126

1.80

36.22

5.8

56.14

56.61

0.73

1063

7686

(3044889) 12 lead EKG panel

1407

11078

1.86

35.83

3.8

3.2

—

(3022096) Basophils/100 leukocytes in Blood

1053

7609

1.79

35.74

5.8

6.1

0.69

0.68

0.29

1005

7146

(3022217) INR in Platelet poor plasma by Coagulation assay

899

6209

1.80

35.52

10.1

10.5

1.07

1.16

inr

5.45

295

1976

(40760892) CBC W Ordered Manual Differential panel - Blood

1087

7948

1.78

35.24

6.3

6.4

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1084

7957

1.77

34.32

6.5

6.0

9.51

10.93

umol/l

5.97

1023

7567

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

508

2960

1.95

34.26

1.4

1.3

6.52

10.75

u/ml

1.19

199

1248

(3002582) Erythrocytes [#/volume] in Urine

687

4436

1.82

33.51

3.6

2.9

65.15

74.35

e6/l

0.08

539

3376

(3018095) Leukocytes [#/volume] in Urine

795

5364

1.79

33.45

4.1

3.3

50.30

74.38

e6/l

0.87

583

3661

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1930

17227

2.96

32.86

17.5

11.5

17.78

21.13

mg/l

5.84

1620

13296

(3037522) Nuclear Ab [Titer] in Serum

442

2492

1.99

32.61

1.5

1.3

521.95

536.53

titre

0.05

496

(3015377) Calcium [Moles/volume] in Serum or Plasma

726

4830

1.78

31.63

2.7

3.3

2.34

2.35

mmol/l

1.14

660

4371

(36304419) Bacteria [Presence] in Urine

628

4030

1.80

30.75

3.3

2.7

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1908

17066

2.64

29.83

17.7

12.4

3.93

3.94

mmol/l

0.73

1879

16608

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

812

5648

1.72

29.79

2.1

1.8

97.04

97.07

pmol/l

0.01

434

3075

(3019550) Sodium [Moles/volume] in Serum or Plasma

1902

16997

2.59

29.62

17.8

12.3

139.68

139.64

mmol/l

0.38

1874

16568

(3018677) aPTT in Platelet poor plasma by Coagulation assay

384

2126

1.99

29.57

2.2

29.18

29.55

0.74

370

2061

(3033658) Prothrombin time (PT) actual/Normal

612

3954

1.78

28.97

4.9

3.7

96.34

94.53

1.08

590

3844

(3030467) Casts [#/volume] in Urine by Automated count

622

4046

1.77

28.72

3.4

2.8

0.32

0.39

e6/l

0.48

478

3026

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1795

15742

2.10

27.89

5.9

4.6

1.66

2.07

mu/l

2.14

1723

14788

(3048689) Calprotectin [Mass/mass] in Stool

404

2329

1.91

27.43

2.4

2.5

97.46

122.67

ug/g

0.84

336

1865

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

914

6667

1.67

27.38

2.5

2.2

76.79

74.41

nmol/l

1.49

853

6147

(40768797) Stomach Pathology biopsy report

380

2160

1.93

26.87

1.3

1.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

438

2612

1.86

26.70

4.4

3.3

142.84

516.75

ng/l

3.42

253

1736

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

252

1237

2.18

26.61

2.4

24.43

22.33

au/ml

0.08

120

(3009261) Glucose [Presence] in Urine by Test strip

1067

8159

1.64

26.09

4.0

3.2

0.00

0.01

estimate

1.06

213

1508

(3035350) Ketones [Presence] in Urine by Test strip

1058

8083

1.64

25.88

4.0

3.2

0.00

estimate

1.08

219

1626

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

633

4241

1.71

25.78

1.4

1.3

0.94

1.51

u/ml

1.67

195

1194

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

112

379

3.07

25.58

1.4

1.5

218.45

1713.09

e6/l

1.07

303

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

112

379

3.07

25.58

1.3

1.4

3.61

14.26

e6/l

2.17

292

(3021601) Nitrite [Presence] in Urine by Test strip

1056

8084

1.63

25.46

5.4

4.3

0.00

estimate

0.50

217

1575

(3012095) Magnesium [Moles/volume] in Serum or Plasma

394

2309

1.87

25.23

3.1

3.5

0.83

0.82

mmol/l

0.71

375

2190

(3015736) pH of Urine

895

6587

1.64

25.23

3.6

3.0

5.85

5.89

0.16

681

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

234

1142

2.18

25.02

1.3

48.66

45.16

au/ml

—

(3000850) Epithelial cells [#/volume] in Urine

483

3034

1.77

24.56

2.8

2.4

6.80

6.53

e6/l

0.13

433

2714

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

796

5718

1.64

24.54

3.7

3.3

27.46

30.95

u/l

4.00

773

5438

(3021960) Folate [Moles/volume] in Serum or Plasma

482

3031

1.77

24.39

1.6

1.5

19.33

20.63

nmol/l

1.29

426

2665

(3023368) Bacteria identified in Blood by Culture

548

3603

1.71

23.55

4.6

4.0

—

(3044290) Cell count panel - Cerebral spinal fluid

105

362

3.00

23.22

1.3

1.5

—

(3026782) Osmolality of Urine

456

2865

1.76

22.98

2.9

2.6

535.06

545.23

mosm/kgh2o

0.39

394

2473

(3007164) IgA [Mass/volume] in Serum or Plasma

554

3674

1.70

22.97

1.5

1.4

2.16

2.30

g/l

1.23

346

2389

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

379

2261

1.83

22.72

3.1

2.6

4.17

2.88

e6/l

0.67

209

1185

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

559

3728

1.69

22.64

2.6

2.1

2.66

2.82

mg/l

0.96

493

3208

(3000570) Elastase.pancreatic [Mass/mass] in Stool

115

428

2.79

22.13

1.4

297.77

300.14

ug/g

0.04

224

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

108

389

2.87

22.09

1.3

1.2

3.64

3.72

mmol/l

0.30

100

361

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1029

7996

1.57

22.06

3.6

2.8

90.13

102.98

ug/l

1.87

984

7541

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

392

2383

1.80

22.02

2.5

2.8

2.42

2.43

mmol/l

1.05

344

2102

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

608

4172

1.65

21.94

1.8

1.6

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

359

2157

1.80

20.87

2.1

1.8

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

391

2411

1.77

20.81

3.0

2.4

0.99

0.97

e6/l

0.05

226

1322

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

270

1488

1.94

20.57

2.9

2.5

33.09

40.62

u/l

0.99

236

1282

(3005719) IgG [Mass/volume] in Serum or Plasma

242

1286

2.00

20.49

2.0

2.7

9.66

10.61

g/l

5.48

221

1184

(3026008) Bacteria identified in Urine by Culture

593

4119

1.62

20.05

3.1

2.5

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

480

3161

1.68

20.04

2.5

2.9

592.98

918.81

ng/l

1.84

383

2610

(3003327) Ova and parasites identified in Stool by Light microscopy

144

628

2.39

20.02

1.9

1.8

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

158

722

2.29

19.73

1.3

1.2

0.99

1.16

u/ml

0.07

(3021589) Normoblasts [#/volume] in Blood

957

7459

1.53

19.28

9.6

8.5

0.00

e9/l

0.52

802

6134

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

260

1455

1.90

18.85

1.9

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

260

1476

1.87

18.00

1.9

1.7

—

(3002032) Base excess in Venous blood by calculation

215

1148

1.97

17.88

3.3

3.4

1.56

1.95

mmol/l

0.85

188

953

(3005322) IgE [Units/volume] in Serum or Plasma

229

1251

1.93

17.82

1.3

162.36

227.07

u/ml

0.82

215

1167

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1782

16123

1.79

17.70

4.4

3.9

5.73

5.80

mmol/l

1.58

1678

15053

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

208

3.30

17.70

1.4

1.3

0.12

0.45

nmol/l

—

(3019150) Specific gravity of Urine by Refractometry

505

3463

1.61

17.65

4.1

3.4

1.02

kg/l

0.21

474

(3023410) Appearance of Cerebral spinal fluid

174

3.52

17.63

1.3

1.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1780

16109

1.78

17.54

14.0

10.1

91.10

89.27

ml/min/173m2

3.57

1538

13243

(40758558) Short blood count panel - Blood

581

4124

1.57

17.50

5.6

6.5

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

302

1818

1.78

17.22

2.9

2.7

6.07

7.61

umol/l

0.97

251

1572

(3019309) Folate [Moles/volume] in Red Blood Cells

353

2221

1.71

17.21

1.8

1.7

1148.76

1177.86

nmol/l

0.25

284

1728

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

123

537

2.37

17.06

1.8

1.7

0.23

g/l

0.24

117

499

(3013512) EKG study

554

3911

1.57

17.01

3.7

3.1

—

(3027801) Oxygen [Partial pressure] in Arterial blood

252

1443

1.85

16.94

7.4

9.1

12.37

12.76

kpa

0.50

243

1389

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

252

1443

1.85

16.94

7.4

9.1

5.00

5.13

kpa

1.35

244

1386

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

126

560

2.33

16.78

1.8

1.7

1.21

1.18

g/l

0.52

120

521

(3003396) Base excess in Arterial blood by calculation

250

1432

1.85

16.78

7.5

9.1

1.13

1.04

mmol/l

0.16

194

1140

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

440

2951

1.62

16.73

1.7

1.6

55958957.17

37367814.14

pmol/l

0.23

386

2545

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1440

12439

1.53

16.52

4.0

3.0

42.81

43.50

u/l

0.15

1376

11854

(3011397) Hemoglobin [Presence] in Urine by Test strip

515

3596

1.58

16.51

3.6

3.2

—

(3016502) Oxygen saturation in Arterial blood

227

1268

1.89

16.47

7.7

9.8

95.76

95.98

0.18

218

1225

(3019060) Gas panel - Arterial blood

160

790

2.11

16.47

4.7

6.3

—

(4200892) Spirometry reversibility

200

1072

1.96

16.42

1.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

211

1157

1.92

16.19

3.4

5.81

5.88

kpa

0.53

206

1122

(3024980) IgG subclass 4 [Mass/volume] in Serum

283

2.83

15.79

1.3

1.8

0.60

0.79

g/l

1.17

215

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1671

15022

1.60

15.07

5.2

4.8

38.22

38.64

mmol/mol

1.20

1600

14196

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

190

3.17

14.73

1.4

1.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

186

1009

1.93

14.72

1.6

1.8

1.12

1.35

g/l

2.14

171

938

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

810

6344

1.46

14.61

4.1

3.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

151

3.44

14.56

1.3

1.8

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

210

1194

1.85

14.37

8.2

10.1

127.77

124.10

g/l

1.57

204

1162

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

194

3.10

14.23

1.1

—

(3022145) Colonoscopy Study observation

283

1770

1.69

13.93

1.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

317

2049

1.65

13.74

2.4

2.3

2.40

2.39

g/l

0.05

299

1912

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

156

822

1.97

13.44

3.3

3.2

5.11

5.17

kpa

0.33

149

789

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

937

7644

1.41

13.05

2.8

2.5

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

179

1000

1.87

12.93

1.7

—

(40761511) CBC panel - Blood by Automated count

1936

18265

2.03

12.92

15.5

10.6

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

190

3.00

12.83

1.3

—

nmol/l

—

(3002385) Erythrocyte distribution width [Ratio]

1673

15206

1.54

12.67

19.1

13.7

14.59

14.70

0.13

1652

14939

(3009343) pH of Capillary blood

152

811

1.94

12.63

3.3

3.2

7.44

7.41

1.90

105

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

201

1176

1.79

12.49

2.8

3.3

4.51

4.56

pmol/l

0.34

184

1061

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.83

12.46

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

162

3.14

12.40

1.3

1.2

29.47

41.58

mg/l

2.30

129

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

143

754

1.96

12.30

1.7

2.1

37.79

39.61

u/l

0.56

131

682

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

159

870

1.90

12.25

2.0

2.9

91.25

135.70

ng/l

1.29

137

773

(3008152) Bicarbonate [Moles/volume] in Arterial blood

145

772

1.94

12.12

6.6

8.5

24.42

24.49

mmol/l

0.08

138

732

(3028707) Methadone [Presence] in Urine by Screen method

103

483

2.19

12.12

2.8

3.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1940

18363

2.00

12.09

11.9

9.2

27.49

27.36

u/l

0.11

1906

17856

(3007853) Bacteria identified in Skin by Aerobe culture

284

1845

1.63

11.98

1.9

1.6

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

285

2.54

11.86

3.2

5.9

324.10

370.25

umol/l

1.70

248

(3028192) IgG subclass 2 [Mass/volume] in Serum

167

3.04

11.79

1.3

2.87

3.01

g/l

0.25

112

(3024139) IgG subclass 3 [Mass/volume] in Serum

167

3.04

11.79

1.3

0.33

0.38

g/l

0.43

112

(3027135) IgG subclass 1 [Mass/volume] in Serum

167

3.04

11.79

1.3

6.14

6.85

g/l

0.95

113

(36660697) Celiac disease serology panel - Serum

235

1463

1.68

11.70

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

230

1425

1.69

11.66

1.3

1.2

102.14

147.19

iu/ml

1.00

549

(3022948) Iron [Moles/volume] in Serum or Plasma

330

2237

1.57

11.62

2.4

2.3

13.92

14.34

umol/l

0.51

309

2096

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

145

788

1.90

11.41

3.2

1.36

1.51

mmol/l

0.18

106

581

(3036489) Thrombin time

122

626

2.01

11.34

1.6

2.1

20.95

20.96

0.01

543

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

155

3.08

11.34

1.3

1.1

245.49

256.26

mg/l

0.20

129

(40768804) Tissue Pathology biopsy report

825

6697

1.39

11.30

2.0

—

(3044640) Blood type and Crossmatch panel - Blood

639

4971

1.41

11.23

2.3

2.2

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

285

1883

1.60

11.19

2.5

2.4

23.09

24.45

0.94

248

1635

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

123

638

1.99

11.10

3.3

3.5

24.11

24.20

mmol/l

0.12

123

626

(3000991) Gas panel - Venous blood

182

1076

1.76

10.91

8.0

9.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

220

2.68

10.88

1.1

—

(3029937) Albumin [Presence] in Urine by Test strip

559

4269

1.42

10.83

4.6

3.5

0.03

0.00

estimate

0.83

216

1534

(4062490) Immunoglobulin typing, IgG

172

2.89

10.62

1.3

—

(3011288) Drugs identified in Urine by Screen method

137

756

1.87

10.30

3.2

3.4

—

(3042936) Bacteria identified in Isolate by Culture

310

2130

1.54

10.20

2.3

2.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

165

967

1.77

10.19

2.1

1.6

292.22

291.06

mu/l

0.02

152

874

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1492

13449

1.40

10.12

4.1

3.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

186

1130

1.71

10.12

1.4

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

190

2.73

9.92

1.7

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

174

2.80

9.84

1.2

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

199

1245

1.66

9.70

1.4

25.17

25.84

iu/l

0.11

175

1063

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

155

2.88

9.51

1.2

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

125

688

1.87

9.49

10.4

12.9

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

439

3287

1.43

9.31

2.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

172

1052

1.69

9.13

1.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

137

2.96

9.10

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

137

2.96

9.10

1.2

1.1

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

261

1770

1.54

9.08

4.3

6.1

1.01

1.04

mmol/l

0.63

244

1666

(3041096) Erythrocytes [Presence] in Urine by Automated

592

4683

1.37

9.04

3.7

2.8

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

194

1228

1.64

9.03

2.2

2.4

79.46

73.67

ml/min/173m2

1.22

443

(3020630) Protein [Mass/volume] in Serum or Plasma

162

979

1.71

8.99

1.7

2.6

68.10

67.45

g/l

0.54

154

913

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

138

2.94

8.98

1.2

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

133

2.97

8.94

1.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

489

3762

1.39

8.82

2.3

2.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

2014

19525

2.54

8.75

24.6

16.9

41.05

41.00

0.08

1935

18588

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

397

2952

1.43

8.69

2.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

136

2.90

8.61

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

136

2.90

8.61

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

136

2.90

8.61

1.2

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

143

845

1.74

8.60

1.6

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

273

2.31

8.56

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

273

2.31

8.56

1.4

1.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

210

1376

1.59

8.48

2.3

2.2

13.21

13.10

nmol/l

0.06

196

1267

(3009214) Lutropin [Units/volume] in Serum or Plasma

120

679

1.81

8.37

1.4

10.91

9.54

u/l

0.53

109

559

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

3.54

8.25

1.1

2.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.37

8.21

1.1

—

(3024731) MCV [Entitic volume]

2014

19557

2.46

8.14

24.3

16.8

90.68

90.36

2.73

2003

19355

(3023420) DNA double strand Ab [Units/volume] in Serum

187

2.55

8.09

1.4

1.6

—

26.80

—

(3010813) Leukocytes [#/volume] in Blood

2014

19560

2.45

8.08

24.5

16.9

6.83

6.67

e9/l

2.24

1986

19125

(3026361) Erythrocytes [#/volume] in Blood

2014

19560

2.45

8.08

24.4

16.8

4.57

e12/l

0.04

1987

19130

(3022313) Gas panel - Capillary blood

107

591

1.85

8.07

3.4

3.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

416

2.01

7.95

1.4

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

163

1020

1.65

7.94

2.4

2.1

4.77

7.65

ug/l

1.14

138

922

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1817

17168

1.50

7.94

4.7

4.2

2.92

2.87

mmol/l

1.30

1725

16235

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

361

2679

1.42

7.94

2.1

1.8

1.50

1.42

1.41

322

2411

(3000963) Hemoglobin [Mass/volume] in Blood

2014

19570

2.43

7.89

24.6

16.9

137.86

137.38

g/l

0.91

2002

19365

(3035941) MCH [Entitic mass]

2013

19557

2.40

7.88

24.3

16.8

30.31

30.19

2.62

2002

19353

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

100

547

1.87

7.78

1.6

2.3

97.54

93.74

0.79

531

(3007461) Platelets [#/volume] in Blood

2011

19539

2.34

7.70

24.5

16.9

263.12

257.05

e9/l

4.44

1989

19134

(3047181) Lactate [Moles/volume] in Blood

428

1.98

7.70

6.0

8.5

1.32

1.23

mmol/l

0.35

371

(3024928) Oxygen saturation in Venous blood

280

2.21

7.67

2.7

2.8

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

123

2.88

7.65

1.1

1.06

u/l

0.03

(3048929) Epstein Barr virus Ab [Presence] in Serum

120

699

1.76

7.61

1.3

1.2

—

(3049717) Cytology report of Urine Cyto stain

430

1.97

7.60

2.1

2.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

3.50

7.55

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

101

560

1.85

7.54

1.7

1.9

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

174

1122

1.60

7.52

2.9

3.7

1.22

1.23

mmol/l

0.94

159

982

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

469

1.92

7.42

1.8

2.2

10.08

10.47

mg/l

0.20

438

(3036180) Methadone [Presence] in Urine

120

2.86

7.38

2.4

3.7

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

533

4262

1.34

7.34

1.7

1.6

1.51

1.42

mmol/l

0.74

453

3675

(3025941) Bacteria identified in Stool by Culture

165

1059

1.61

7.28

1.3

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

179

2.49

7.27

1.3

1.5

373.56

393.28

pmol/l

0.11

158

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

517

1.86

7.21

5.4

7.3

1.82

1.63

0.99

482

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

128

2.76

7.13

1.1

1.2

1.07

1.04

ratio

0.71

(3016879) Cocaine [Presence] in Urine

158

1009

1.61

7.12

2.4

2.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1792

16974

1.43

6.85

4.3

3.9

4.78

4.77

mmol/l

0.36

1709

16141

(3010421) pH of Blood

376

1.98

6.83

3.5

3.6

7.42

0.18

337

(3026493) Urate [Moles/volume] in Serum or Plasma

505

4044

1.33

6.81

2.2

2.4

3396.59

4112.52

umol/l

0.17

449

3628

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

399

1.94

6.73

1.3

1.2

30.39

41.85

u/ml

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

138

865

1.64

6.71

2.6

2.5

—

(3000764) Benzodiazepines [Presence] in Urine

166

1089

1.57

6.69

2.4

—

(3000494) Fungus identified in Specimen by Culture

270

1959

1.44

6.67

1.5

1.4

—

(3011985) Renin [Units/volume] in Plasma

187

2.38

6.64

1.3

1.5

54.95

46.32

mu/l

0.18

168

(1002224) Polysomnography panel

145

926

1.61

6.55

1.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

468

1.85

6.53

1.9

2.3

302.07

381.89

ug/l

0.19

431

(3009508) Creatinine [Moles/volume] in Urine

551

4491

1.31

6.52

2.9

3.4

8.25

8.16

mmol/l

0.15

485

3891

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

484

1.83

6.47

1.8

2.6

3.56

3.59

g/l

0.06

456

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

267

2.13

6.46

1.8

1.6

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

349

1.98

6.44

2.9

3.6

0.34

u/ml

0.02

186

(3004588) Protein electrophoresis panel - Serum or Plasma

129

804

1.64

6.42

1.6

2.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.60

6.31

1.1

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

3.18

6.29

1.1

1.2

0.28

0.29

g/l

0.21

(3027945) Reticulocytes/100 erythrocytes in Blood

193

1327

1.50

6.28

2.4

2.8

1.65

1.76

0.98

170

1198

(3027008) Opiates [Presence] in Urine

165

1097

1.55

6.28

2.4

2.2

—

(3027944) Amphetamines [Presence] in Urine

162

1075

1.55

6.22

2.4

2.3

—

(3028300) Cannabinoids [Presence] in Urine

165

1101

1.54

6.18

2.4

—

(3020891) Body temperature

484

1.81

6.18

5.0

4.9

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1781

16910

1.40

6.17

4.3

3.8

1.42

1.45

mmol/l

3.41

1700

16006

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

104

2.81

6.16

1.2

1.1

—

(3012501) Base excess in Blood by calculation

322

1.99

6.06

3.7

2.33

2.23

mmol/l

0.11

204

(3023511) Choriogonadotropin [Units/volume] in Urine

100

594

1.72

5.98

1.4

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

166

1118

1.53

5.96

2.4

2.3

6217.55

5605.20

u/l

0.07

432

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

527

1.76

5.95

1.3

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

527

1.76

5.95

1.3

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

114

706

1.65

5.84

1.6

1.7

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

472

1.79

5.78

1.4

1.2

4.53

8.44

u/ml

0.50

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

356

1.91

5.77

1.2

4.98

4.10

u/ml

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

465

1.80

5.76

1.5

1.2

19.80

2.32

u/ml

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

116

725

1.64

5.74

1.7

1.6

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.93

5.73

7.6

3.3

93.64

130.16

umol/l

0.54

(3020911) Cortisol [Moles/time] in 24 hour Urine

3.48

5.73

1.2

1.4

65.29

82.79

nmol/24h

0.69

(42529406) Shigella sp [Presence] in Stool by Culture

534

1.74

5.70

1.3

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

543

1.73

5.65

1.6

1.3

—

(3008898) HLA-B27 [Presence]

126

809

1.59

5.60

1.1

—

(3021901) Oxygen saturation in Capillary blood

216

2.16

5.56

3.0

2.5

—

(3045414) Leukocytes [Presence] in Urine

113

710

1.63

5.49

1.8

1.7

—

(3039000) Anion gap in Blood

292

1.98

5.48

7.0

10.7

10.81

11.56

mmol/l

1.12

263

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

147

2.40

5.48

1.4

3.5

—

(3018572) Chloride [Moles/volume] in Blood

293

1.97

5.43

7.0

10.7

105.23

105.54

mmol/l

0.18

264

(3020961) Endomysium IgA Ab [Titer] in Serum

144

962

1.53

5.39

1.1

—

175.84

—

(3000060) B lymphocytes [#/volume] in Blood

3.74

5.37

1.6

2.0

271.11

179.17

e6/l

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

2.88

5.35

1.5

—

76.80

—

(3025159) Blasts/100 leukocytes in Blood

173

1203

1.48

5.35

3.8

4.5

0.05

0.37

0.65

305

(3017181) Myelocytes/100 leukocytes in Blood

188

1329

1.46

5.34

3.8

4.3

0.62

0.95

1.51

432

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

233

2.09

5.34

1.7

1.5

—

(3011412) CD3 cells [#/volume] in Blood

155

2.35

5.34

1.4

2.5

1.52

1.31

e9/l

0.68

143

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

274

2.00

5.34

1.1

1.2

—

33.33

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

231

1698

1.41

5.30

7.0

5.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

404

1.81

5.27

1.6

2.3

9.56

10.56

g/l

1.61

373

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

501

1.73

5.26

1.9

2.5

172.97

173.97

0.04

478

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

510

1.72

5.21

1.3

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

202

2.15

5.21

1.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.49

5.17

1.2

1.1

—

(3022621) pH of Urine by Test strip

147

996

1.51

5.16

2.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

315

1.90

5.05

1.3

1.2

4.35

4.03

u/ml

0.06

101

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

366

1.83

5.03

1.8

1.7

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

166

2.25

5.02

1.8

2.0

19.57

20.04

nmol/l

0.11

159

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

418

1.77

5.01

1.6

2.3

2.72

2.86

g/l

0.83

388

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

219

2.08

4.99

1.2

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

434

1.76

4.97

2.4

2.9

—

(40767503) Oxygen content in Capillary blood by calculation

283

1.93

4.90

3.4

2.4

16.63

16.82

0.10

139

(3023520) Reticulocytes [#/volume] in Blood

139

942

1.51

4.89

2.4

2.8

67.82

73.08

e9/l

1.13

103

702

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

199

1446

1.42

4.89

3.2

4.4

214.49

244.34

u/l

2.81

193

1378

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

199

1447

1.42

4.87

3.3

2.9

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

363

1.82

4.85

1.8

1.7

—

(3040151) Glucose [Moles/volume] in Capillary blood

143

2.33

4.85

3.7

5.9

9.66

7.14

mmol/l

0.33

119

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

439

1.74

4.79

1.6

2.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

439

1.74

4.79

1.6

2.2

3.44

3.65

g/l

1.05

409

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

439

1.74

4.79

1.6

2.2

7.24

7.20

g/l

0.08

409

(3002179) Metamyelocytes/100 leukocytes in Blood

172

1227

1.44

4.68

3.5

4.1

0.37

0.70

1.39

374

(3021440) Promyelocytes/100 leukocytes in Blood

177

1270

1.43

4.67

3.8

4.4

0.00

0.12

7.39

373

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

535

1.65

4.64

3.6

3.4

51.71

49.89

0.29

530

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

105

677

1.58

4.63

2.3

2.2

—

(3004616) Nuclear Ab [Presence] in Serum

201

2.06

4.50

1.4

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

299

1.86

4.50

1.0

1.1

133.56

116.10

3.40

278

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

117

2.41

4.48

1.4

2.6

508.77

582.91

e6/l

0.29

103

(46235355) HIV 1 and 2 tests - Meaningful Use set

533

4506

1.25

4.45

2.0

—

(3019225) pH of Specimen

187

1369

1.40

4.41

3.9

3.8

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

113

2.41

4.31

1.4

2.6

0.18

0.22

e9/l

1.12

102

(3030313) Adrenal Ab [Titer] in Serum

6.27

4.29

1.0

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

305

1.83

4.24

2.6

2.3

132.39

132.96

g/l

0.06

222

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1705

16273

1.28

4.23

3.9

3.5

1.38

1.30

mmol/l

3.70

1621

15344

(1616796) Gas panel - Central venous blood

313

1.81

4.21

4.1

3.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

183

1350

1.39

4.14

2.3

0.22

g/l

0.00

173

1268

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

5.90

4.13

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

253

1.88

3.99

1.5

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

494

1.62

3.99

1.6

2.0

4.59

4.82

iu/l

0.07

190

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

306

1.79

3.91

1.3

1.2

3.00

4.76

u/ml

0.82

123

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

3.27

3.91

1.2

1.0

94.14

98.42

0.29

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

2.46

3.88

1.0

1.1

101.56

93.04

0.70

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

337

1.74

3.86

1.4

1.5

—

(3000492) Spirometry study

248

1942

1.32

3.82

1.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

3.96

3.79

1.1

1.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

517

1.59

3.78

2.2

1.8

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

517

1.59

3.78

1.2

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

113

778

1.48

3.74

2.4

1.8

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

109

2.31

3.69

1.6

2.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

203

1.94

3.68

1.6

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

203

1.94

3.68

1.7

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

290

1.78

3.67

1.0

1.1

—

(3017732) Neutrophils [#/volume] in Blood

162

1201

1.38

3.59

2.3

2.7

6.31

5.46

e9/l

0.21

138

1040

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

198

1.94

3.59

1.1

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

150

2.08

3.57

1.1

1.4

—

(3003338) MCHC [Mass/volume]

1627

15530

1.23

3.51

20.9

14.2

333.46

333.34

g/l

0.23

1622

15422

(40761536) Microorganisms panel - Urine sediment

188

1432

1.34

3.51

4.6

3.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

347

1.69

3.51

1.7

2.3

41.48

38.52

g/l

3.58

317

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

496

1.57

3.49

2.1

2.55

1.92

ug/l

0.22

446

(40761535) Cells panel - Urine sediment

157

1164

1.38

3.48

3.6

3.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

379

1.66

3.47

1.7

2.5

0.25

0.86

g/l

1.48

345

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

403

1.63

3.44

1.3

1.2

293.18

251.32

u/ml

0.25

257

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

146

2.07

3.42

1.1

1.2

0.20

0.67

u/ml

1.50

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

571

1.53

3.41

2.3

1.9

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

282

1.76

3.41

1.4

3.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

5.73

3.34

1.1

1.0

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

4.36

3.31

6.5

4.4

39.60

44.39

umol/l

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

424

1.60

3.28

2.1

1.6

—

(44813793) Dust mix specific IgE antibody measurement

135

2.09

3.28

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

264

1.76

3.24

1.7

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

264

1.76

3.24

1.7

1.6

—

(3003181) Sodium [Moles/volume] in Urine

213

1.85

3.23

1.3

66.71

66.83

mmol/l

0.01

185

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

103

2.25

3.22

1.4

2.0

0.86

2.12

u/field

1.33

(3002079) Sodium [Moles/time] in 24 hour Urine

2.45

3.21

1.2

1.3

143.00

173.85

mmol/24h

0.72

(3047007) Chlamydophila sp Ab [Presence] in Serum

295

1.71

3.21

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

4.18

3.19

3.7

2.8

—

(3011648) Oxygen content in Venous blood

110

2.20

3.19

2.5

2.1

10.18

11.26

0.54

110

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.87

3.19

1.2

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.87

3.19

1.2

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

556

1.51

3.18

1.0

1.1

2.09

4.10

u/ml

—

(3042631) Mycobacterium sp identified in Specimen

158

1.98

3.15

3.2

2.8

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

474

4094

1.21

3.10

4.2

4.0

1.80

1.97

ug/l

0.51

422

3728

(3006653) Thiamine [Moles/volume] in Blood

2.34

3.08

1.4

1.5

129.65

142.53

nmol/l

0.46

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

189

1.87

3.02

1.6

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

189

1.87

3.02

1.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

426

1.57

3.00

1.3

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

379

1.60

2.99

1.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

302

2502

1.24

2.97

1.7

1.6

—

(3011897) Casein IgE Ab [Units/volume] in Serum

3.26

2.93

1.3

1.1

0.03

0.11

u/ml

0.52

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

160

1228

1.33

2.88

3.2

4.3

9.66

26.56

ug/l

0.94

124

973

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.60

2.87

1.3

1.5

—

(3032773) Endomysium IgG Ab [Titer] in Serum

178

1.87

2.87

1.1

—

(3012516) Albumin [Mass/volume] in Urine

446

3858

1.20

2.85

3.0

3.4

1107.69

284.47

mg/l

1.53

281

2535

(3013247) Albumin in CSF/Albumin in Serum or Plasma

3.17

2.85

1.1

1.0

6.86

7.10

mg/g

0.06

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

2.41

2.80

2.0

2.4

0.44

1.06

ug/l

2.35

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

404

1.55

2.74

1.4

0.27

0.40

nmol/l

1.67

335

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

125

2.01

2.71

3.3

3.1

41372.00

41188.84

ug/l

0.03

125

(3017704) Immunofixation for Urine

2.51

2.70

1.1

1.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

350

1.59

2.69

1.7

1.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.29

2.67

1.0

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

4.68

2.59

1.0

1.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

107

2.07

2.57

1.1

1.3

4.36

6.60

u/l

2.01

(3038026) Centromere Ab [Units/volume] in Serum

128

1.96

2.55

1.4

1.2

—

68.02

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

5.47

2.54

1.2

1.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

317

1.59

2.50

1.0

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.33

2.48

1.1

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

3.47

2.48

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

210

1.73

2.47

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

231

1907

1.24

2.37

2.2

1.9

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

374

3246

1.19

2.29

4.0

3.5

21.22

21.08

0.05

152

1296

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.28

2.24

1.1

91.20

95.70

—

(3025130) Human papilloma virus identified in Specimen

303

1.56

2.23

1.8

1.7

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

2.10

2.23

1.8

2.6

23.91

393.43

ug/l

0.67

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

394

1.49

2.17

2.9

3.0

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

386

1.49

2.17

1.4

—

19.13

—

(3020682) Albumin/Creatinine [Ratio] in Urine

456

4043

1.16

2.15

3.6

3.9

8.39

8.82

mg/mmol

0.06

281

2636

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

4.30

2.15

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

3.69

2.15

1.0

—

(40768443) Skin Pathology biopsy report

622

1.38

2.14

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.63

2.14

4.2

4.9

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

137

1.83

2.13

1.2

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

251

1.61

2.13

1.5

1.6

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

213

1.65

2.10

2.5

2.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

340

1.51

2.10

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.21

2.09

1.1

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

390

1.47

2.08

2.0

2.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

161

1.75

2.06

1.9

—

(3023419) Bacteria identified in Sputum by Culture

207

1.65

2.04

1.9

2.8

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

192

1.68

2.03

1.3

1.6

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.34

1.96

1.0

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.34

1.96

1.1

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

281

1.54

1.95

1.2

1.3

—

(3051651) Icteric interference index of Serum or Plasma

1.95

2.3

3.5

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

338

1.49

1.95

5.6

6.3

2733.33

381.18

iu/ml

—

(21494755) Public health laboratory ask at order entry panel

214

2539

0.82

1.94

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.20

1.94

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.57

1.94

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.57

1.94

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.57

1.94

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.57

1.94

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

258

1.56

1.93

1.9

1.8

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

2.01

1.90

2.4

3.2

401.94

750.39

u/ml

1.93

(3002523) Influenza virus A Ag [Presence] in Specimen

407

1.44

1.88

1.2

1.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

121

954

1.29

1.88

3.2

3.8

69.19

79.06

ng/l

0.98

109

864

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

358

1.46

1.87

1.6

1.4

126.11

106.32

u/ml

0.38

(3044242) Glucose [Moles/volume] in Arterial blood

2.09

1.86

1.5

2.8

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.86

1.86

1.0

1.5

—

(3042517) Benzodiazepines panel - Urine

2.86

1.86

2.0

2.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.40

1.85

1.1

1.2

—

(3045424) Erythrocytes [Presence] in Urine

277

1.53

1.85

1.7

1.5

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.54

1.84

1.0

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

4.17

1.82

2.2

2.1

34.40

36.33

umol/l

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

4.17

1.82

1.0

1.2

7.20

10.17

u/l

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

327

1.48

1.82

1.5

3.7

25.56

40.83

mg/l

0.84

257

(3034860) Kappa light chains.free [Mass/volume] in Serum

327

1.48

1.82

1.5

3.7

35.18

66.08

mg/l

0.84

256

(3051611) Lipemic interference index of Serum or Plasma

138

1.75

1.79

2.4

3.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

320

1.48

1.79

1.0

1.1

1.70

2.15

u/ml

0.40

165

(3028679) Herpes simplex virus Ab [Presence] in Serum

116

1.82

1.78

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

183

1524

1.22

1.78

2.0

1.8

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

289

2510

1.18

1.78

1.5

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

109

1.84

1.77

2.0

1.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

405

1.42

1.75

1.2

1.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

3.34

1.74

1.0

0.15

0.24

u/ml

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.23

1.74

1.2

1.1

—

(3002619) Bacteria identified in Specimen by Culture

2.67

1.72

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

266

1.51

1.71

1.3

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

234

1.55

1.71

3.1

3.8

68.54

1321.56

u/ml

0.64

220

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.01

1.69

1.0

1.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.51

1.66

1.4

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

2.51

1.66

1.0

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

302

1.47

1.63

1.2

1.1

3209.20

1630.36

iu/ml

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

120

1.76

1.62

3.1

3.8

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.70

1.58

1.1

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

129

1.71

1.56

2.0

1.4

70.14

73.96

umol/l

0.56

129

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.98

1.54

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

2.60

1.51

1.1

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

135

1112

1.23

1.49

1.4

—

(3034426) Prothrombin time (PT)

2.01

1.48

1.5

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

190

1620

1.19

1.48

1.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

2.50

1.45

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.50

1.45

1.6

1.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.12

1.44

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

3.13

1.44

1.4

1.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

253

1.47

1.43

1.3

3.7

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

114

1392

0.81

1.42

1.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

371

1.38

1.42

1.3

1.4

26.48

23.21

u/l

0.31

311

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

157

1.60

1.40

1.3

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

189

1.54

1.40

1.4

1.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.26

1.40

1.6

3.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.26

1.40

1.6

3.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.08

1.38

1.5

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

142

1.63

1.38

1.3

—

(3002256) Pathology report gross observation

232

2024

1.16

1.38

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.95

1.38

1.0

1.2

—

(3008295) Osmolality of Serum or Plasma

174

1.56

1.37

1.4

1.5

284.79

282.49

mosm/kgh2o

0.19

138

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

143

1.62

1.35

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

191

1.53

1.35

1.3

1.6

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.15

1.33

1.0

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

243

2135

1.16

1.33

1.8

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.04

1.33

1.2

1.1

—

(3028433) Virus identified in Specimen by Culture

1.97

1.32

1.2

1.3

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

463

1.33

1.32

1.8

1.9

184.25

205.08

pmol/l

0.90

440

(3020874) Milk IgE Ab [Units/volume] in Serum

145

1.59

1.29

1.1

1.0

0.23

3.93

u/ml

0.95

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.09

1.27

1.0

1.2

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

345

1.37

1.27

3.3

4.1

55.30

56.55

0.33

345

(3030905) Polymorphonuclear cells [#/volume] in Blood

337

1.37

1.26

3.0

3.7

4.04

e9/l

0.01

337

(3052592) Norovirus Ag [Presence] in Stool

2.40

1.24

1.3

1.5

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

205

1789

1.16

1.24

4.5

3.9

31.01

31.26

0.13

167

1323

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

189

1.49

1.19

1.4

1.6

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

189

1.49

1.19

1.4

1.6

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

190

1.48

1.16

1.4

1.6

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

447

1.31

1.16

2.5

3.2

1.25

1.39

mg/l

0.69

419

(3015076) Soybean IgE Ab [Units/volume] in Serum

142

1.56

1.14

1.0

0.09

2.75

u/ml

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.34

1.12

1.0

1.3

—

(4034850) Laboratory test

530

1.27

1.11

10.9

8.0

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

160

1.51

1.09

1.2

1.6

44.75

55.72

0.55

103

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

2.38

1.09

2.8

7.4

0.47

0.35

umol/l

—

(3035320) C reactive protein [Mass/volume] in Body fluid

120

1.59

1.08

2.6

2.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

261

1.39

1.07

1.5

1.6

—

(3009871) Measles virus Ab [Titer] in Serum

1.76

1.06

1.9

1.7

—

(4094501) Cardiovascular stress test using bicycle ergometer

436

1.29

1.06

1.0

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

2.12

1.05

4.3

13.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.12

1.05

1.0

1.2

—

(40768441) Liver Pathology biopsy report

129

1.56

1.05

1.9

1.5

—

(3044927) Protein electrophoresis panel - Urine

121

1.58

1.05

1.2

1.1

—

(3000330) Specific gravity of Urine by Test strip

652

1.24

1.04

3.2

2.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

162

1.49

1.04

1.7

1.8

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

179

1.46

1.03

1.7

1.8

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.06

1.03

1.7

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.06

1.03

1.7

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.06

1.03

1.7

1.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.84

1.03

1.1

3.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

456

1.28

1.02

2.9

3.8

109.07

3122.66

u/ml

0.76

388

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

755

1.21

1.01

1.4

1.5

—

(3029075) Extractable nuclear Ab panel - Serum

1.89

1.01

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.00

1.00

1.7

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

521

1.26

0.99

1.4

1.9

1.42

1.47

g/l

0.19

453

(3037756) Immunofixation for Serum or Plasma

223

1.40

0.98

1.4

1.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

433

1.28

0.97

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.78

0.94

1.1

—

(3037121) Protein [Mass/volume] in Urine

508

1.25

0.93

2.7

3.8

0.29

0.26

g/l

0.10

227

(3020650) Glucose [Presence] in Urine

1.73

0.92

1.4

—

(4146454) Self-monitoring of blood glucose

142

1.48

0.92

2.3

2.7

—

(3004809) Band form neutrophils/100 leukocytes in Blood

218

1.38

0.91

2.2

3.5

1.08

1.40

0.18

203

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

102

0.49

0.89

1.2

—

(3048879) Bone marrow aspiration report

2.07

0.89

1.2

2.6

—

(3001556) Androgen free Index in Serum or Plasma

2.07

0.89

1.0

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

160

1.44

0.89

1.8

2.1

31.38

23.07

mg/l

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.91

0.88

4.1

2.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.65

0.88

2.3

1.7

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.65

0.88

2.3

1.7

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.79

0.87

1.6

1.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

266

2426

1.11

0.86

2.6

0.70

0.69

ug/l

0.06

159

1395

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

603

0.79

0.86

1.5

1.7

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.82

0.86

1.6

1.9

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.59

0.84

2.2

1.7

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

810

1.18

0.83

1.5

1.3

249.48

218.16

miu/ml

0.38

411

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

796

0.82

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

373

1.27

0.81

1.2

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.67

0.78

1.0

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.78

0.0

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

148

1.42

0.78

1.0

0.30

0.86

u/ml

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

539

0.79

0.77

1.3

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

314

1.28

0.76

1.9

1.5

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

1.70

0.75

1.1

30.10

44.72

u/ml

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

161

0.62

0.75

1.2

1.9

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.09

0.74

1.2

1.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

100

868

1.16

0.72

1.7

2.27

4.63

mg/l

2.26

615

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.00

0.72

1.0

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.61

0.72

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

563

1.20

0.71

1.7

1.6

366.67

0.26

iu/ml

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

1.75

0.71

1.6

1.3

57.43

54.64

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

408

1.23

0.71

1.1

0.53

1.89

u/ml

3.29

196

(3025018) Bordetella pertussis Ab [Titer] in Serum

109

1.47

0.71

1.3

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

728

0.83

0.70

1.5

1.4

—

(3017509) Phencyclidine [Presence] in Urine

1.93

0.70

1.2

—

(40768806) Pleura Pathology biopsy report

1.51

0.69

1.6

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

152

1.39

0.69

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.60

0.68

1.1

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

196

2144

0.91

0.66

1.9

1.6

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

732

0.84

0.65

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

731

0.84

0.64

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

731

0.84

0.64

1.5

1.4

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

166

0.66

0.64

8.7

13.9

726.45

835.43

nmol/l

0.29

160

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

359

1.23

0.64

3.0

2.6

1.15

0.87

nmol/l

1.05

307

(3005011) Chlamydia sp Ab [Titer] in Serum

1.73

0.64

1.2

1.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

470

1.20

0.62

1.1

2.89

2.78

u/ml

0.02

231

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.64

0.62

2.0

1.8

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

443

1.20

0.62

1.1

5.76

6.31

u/ml

0.09

229

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

1.67

0.61

3.0

1.6

5.08

1209097.28

nmol/l

—

(3014271) Vancomycin [Susceptibility]

1.60

0.61

3.8

2.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

139

0.65

0.60

1.0

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

139

1.37

0.60

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.53

0.59

1.1

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

114

1.41

0.59

1.3

1.7

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

1.48

0.57

1.1

13.88

10.37

u/l

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

132

1.37

0.57

2.2

2.3

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

115

1.39

0.56

2.1

2.6

49.40

44.58

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

311

1.23

0.55

2.4

2.2

6.21

5.00

umol/l

0.29

228

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

206

0.73

0.55

1.2

1.6

8.27

7.63

mmol/l

0.48

198

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

133

1.36

0.55

1.7

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

133

1.36

0.55

1.7

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

133

1.36

0.55

1.7

1.6

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

1.47

0.54

1.0

1.1

—

7.93

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.58

0.54

1.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

294

1.23

0.54

4.7

3.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

195

1.29

0.54

1.6

1.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

665

1.15

0.54

1.4

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

169

1.31

0.53

1.2

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.54

0.53

1.0

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

359

1.20

0.53

1.6

1.8

—

(3000093) Morphology [Interpretation] in Blood Narrative

117

1.37

0.52

1.2

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

323

1.21

0.52

4.6

3.0

23.03

23.27

mg/l

0.01

202

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

364

3451

1.07

0.52

1.5

—

(4035726) Immunohistochemistry procedure

117

1293

0.90

0.51

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.41

0.51

2.2

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.41

0.51

2.2

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.41

0.51

2.2

1.9

—

(3017569) Oxygen content in Arterial blood

1.41

0.51

1.4

3.0

—

(3000012) Reticulocyte production index

144

1.32

0.50

1.4

2.4

—

(3006462) Nitrate [Presence] in Urine

1.49

0.49

2.6

2.4

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

154

1.30

0.48

1.3

2.3

33.20

32.58

0.37

154

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.45

0.48

2.0

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.45

0.48

2.0

1.8

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

419

1.17

0.48

1.1

0.56

1.25

u/ml

0.93

165

(3038177) Helicobacter pylori Ab [Presence] in Serum

336

1.19

0.47

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

128

1.33

0.47

2.8

2.6

—

(40768795) Lymph node Pathology biopsy report

154

0.71

0.47

1.2

—

(3012441) Differential panel - Pleural fluid

1.41

0.47

1.8

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

781

0.88

0.46

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

130

1.31

0.44

1.4

1.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

912

0.89

0.43

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

331

1.18

0.43

1.5

1.6

5074.54

11089.14

e6/l

1.25

242

(3044941) Cell count panel - Synovial fluid

221

1.22

0.42

1.3

1.4

—

(40762814) Titanium [Mass/volume] in Blood

0.00

0.41

0.0

2.2

—

3.53

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

1.36

0.41

1.8

1.9

—

137.98

—

(3003694) ABO and Rh group [Type] in Blood

539

5208

1.05

0.40

1.6

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

1.39

0.40

1.5

1.1

6.55

16.26

u/l

4.56

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

138

1490

0.92

0.40

1.6

1.4

—

(3036670) Protein [Mass/volume] in Synovial fluid

1.47

0.40

1.2

—

38.12

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.47

0.40

1.0

1.7

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.33

0.40

1.6

1.9

—

(3024471) HLA-A [Type]

1.33

0.40

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.33

0.40

3.1

—

(3024932) HLA-DR beta [Type]

1.33

0.40

1.0

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

2.4

—

1.09

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

1.1

—

44.93

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

103

0.68

0.39

1.1

1.2

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

0.00

0.39

0.0

3.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

270

1.19

0.38

1.5

1.6

—

(3042733) HLA Ab [Presence] in Serum

1.37

0.38

4.7

4.8

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

1.35

0.37

1.8

1.3

1.20

3.29

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

1.39

0.37

1.1

1.2

—

72.22

—

(3024263) Appearance of Synovial fluid

1.29

0.36

1.6

1.4

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

1.36

0.36

1.5

1.1

71.73

81.07

u/l

0.26

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

168

0.77

0.35

1.4

1.5

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.68

0.33

1.2

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

247

1.18

0.33

2.3

2.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

676

0.90

0.32

1.6

1.5

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

1.35

0.32

1.1

1.3

—

1075.00

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

229

1.18

0.32

1.1

1.2

—

(3035880) pH of Pleural fluid

1.32

0.30

1.1

1.2

—

(3021788) Differential panel - Synovial fluid

249

1.17

0.30

1.4

1.6

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.30

0.30

4.4

2.0

9.67

16.32

umol/l

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

129

1.24

0.30

1.4

1.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

335

1.14

0.29

1.2

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

366

0.87

0.29

1.5

1.6

—

(3041806) Other cells [#/volume] in Blood by Manual count

110

0.73

0.28

1.7

1.6

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

121

1.24

0.28

1.2

1.4

17.50

33.55

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

167

1.20

0.28

1.6

1.4

167.76

224.35

pmol/l

0.44

167

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

112

1.25

0.28

1.6

2.0

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

103

1.26

0.28

1.5

1.4

12.08

27.05

umol/l

5.01

(21494890) Protein electrophoresis panel - 24 hour Urine

119

0.76

0.27

1.8

2.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.23

0.27

2.4

3.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

376

3645

1.04

0.26

1.7

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.30

0.26

1.4

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

330

1.12

0.25

1.1

3.08

4.71

u/ml

0.58

127

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.71

0.24

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

303

1.12

0.23

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

619

0.92

0.23

1.5

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.25

0.22

5.4

7.1

—

(3045142) Bone marrow Pathology biopsy report

146

0.82

0.22

1.4

—

(40758358) Immune stain study

0.00

0.21

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.21

0.0

1.0

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

3.3

—

63.40

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.1

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.04

—

(3015183) Erythrocyte sedimentation rate

126

1.19

0.21

1.1

1.2

—

(3014891) Appearance of Pleural fluid

0.00

0.21

0.0

1.5

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.00

0.20

0.0

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.25

0.20

1.5

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

255

2630

0.97

0.19

1.8

1.7

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

603

0.93

0.19

1.5

1.4

—

(3020491) Glucose [Moles/volume] in Blood

127

1.18

0.19

1.5

1.7

7.56

6.33

mmol/l

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

333

0.90

0.19

1.9

2.3

156.18

151.10

ug/min

0.02

213

(3014148) Varicella zoster virus Ab [Titer] in Serum

289

1.11

0.19

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.13

0.18

1.7

1.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.13

0.17

1.9

1.4

9.10

8.23

ug/l

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

101

1.19

0.16

1.1

1565.33

1605.74

miu/ml

0.05

101

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.16

0.16

1.6

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.11

0.16

1.3

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

149

1.14

0.15

1.0

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

128

0.86

0.13

1.2

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

128

0.86

0.13

1.2

1.0

—

(3005033) Fetal Nuchal fold Thickness US

601

0.95

0.13

1.5

1.4

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

229

1.09

0.12

2.5

3.2

6.23

75.27

u/ml

0.70

224

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

810

0.96

0.10

1.7

1.9

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

310

1.07

0.10

1.1

1.40

0.30

u/ml

0.40

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

124

0.89

0.09

1.6

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

126

1.11

0.09

1.1

1.4

1.68

1.56

g/l

0.95

126

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.07

0.08

1.2

2.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.07

0.08

1.2

2.0

—

(3003434) Protein [Mass/volume] in Pleural fluid

107

1.12

0.08

1.8

1.4

38.09

33.85

g/l

0.46

(3004451) EKG impression Narrative

1.06

0.08

1.6

1.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

1.03

0.07

4.6

5.7

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.03

0.07

2.3

2.9

—

(40768446) Kidney Pathology biopsy report

0.86

0.07

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

0.86

0.07

1.3

1.5

—

(3045788) Cell count panel - Pleural fluid

1.08

0.07

1.8

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.05

0.07

1.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

153

0.91

0.07

2.6

4.1

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.06

0.07

1.0

1.1

83.94

203.37

iu/ml

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.06

0.07

2.2

1.7

—

(21494434) Karyotype in Bone marrow

109

1.10

0.06

1.1

1.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

120

0.92

0.05

1.0

1.1

—

(40768793) Breast Pathology biopsy report

393

0.97

0.04

1.2

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

209

1.05

0.04

1.3

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

251

0.96

0.04

4.2

4.0

18.88

25.75

u/ml

0.69

246

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

170

1.06

0.04

3.3

4.6

51.07

102.70

u/ml

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

319

1.04

0.03

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

131

1.07

0.03

1.4

—

(4281824) Cell count and differential, peritoneal fluid

158

0.95

0.02

1.1

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

123

1.06

0.01

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

137

0.95

0.01

1.2

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

137

0.95

0.01

1.2

1.3

3334.29

81621.62

e6/l

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

116

0.95

0.00

1.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

144

1.04

0.00

1.4

1.6

0.99

0.97

g/l

0.07

144

(3045683) HLA typing for celiac disease panel - Blood or Tissue

145

1.03

0.00

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.01

0.00

1.2

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

329

1.00

0.00

1.2

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

135

1345

1.00

0.00

1.7

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

176

1.02

0.00

1.1

1.0

—

(40768800) Prostate Pathology biopsy report

214

0.98

0.00

1.4

1.2

—

(1761868) Lipid panel - Serum or Plasma

714

7143

1.00

0.00

2.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

362

0.99

0.00

1.1

4.92

3.32

u/ml

0.20

167

(3006270) Folate [Moles/volume] in Blood

122

0.98

0.00

1.0

1.1

496.17

397.68

nmol/l

0.79

114

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

383

0.99

0.00

1.3

1.2

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

-0.00

0.0

4.8

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.2

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

-0.00

0.0

5.0

—

416.43

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

100

1.00

-0.00

5.2

6.9

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

1.60

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.1

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

0.95

-0.00

1.3

1.4

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

-0.00

0.0

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.3

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

8.0

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

-0.00

0.0

2.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

0.87

-0.00

1.3

1.5

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

0.89

-0.00

54.4

25.2

113.86

123.18

ug/l

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.00

-0.00

1.7

2.2

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

-0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3047185) IgG [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

-0.00

0.0

1.2

—

65.38

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

-0.00

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.6

—

7.60

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

2.25

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.00

-0.00

3.0

3.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

-0.00

0.0

4.3

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3026470) Cobalt [Mass/volume] in Blood

0.89

-0.00

1.6

2.1

3.46

3.22

ug/l

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

-0.00

0.0

1.8

—

(3022670) pH of Venous cord blood

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_CLUSTHEADACHE_STRICT_INCLAVO and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_CLUSTHEADACHE_STRICT_INCLAVO	0.92 [0.76, 1.12]	0.401
Birth year	0.992 [0.98, 1.0]	0.079

During the follow-up period (1.1.1998 — 31.12.2019), 184 out of 4534 females with G6_CLUSTHEADACHE_STRICT_INCLAVO died.

Males

Parameter	HR [95% CI]	p-value
G6_CLUSTHEADACHE_STRICT_INCLAVO	1.18 [1.02, 1.36]	0.022
Birth year	0.987 [0.98, 1.0]	0.01

During the follow-up period (1.1.1998 — 31.12.2019), 377 out of 5156 males with G6_CLUSTHEADACHE_STRICT_INCLAVO died.

Mortality risk

Mortality risk for people of age

years, who have G6_CLUSTHEADACHE_STRICT_INCLAVO.

N-year risk	Females	Males
1	0.061%	0.231%
5	0.422%	1.241%
10	1.148%	3.496%
15	2.343%	6.482%
20	4.264%	10.817%

Relationships between endpoints

↥

Index endpoint: G6_CLUSTHEADACHE_STRICT_INCLAVO – Cluster headache, strict, including avohilmo

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Cluster headache, strict, including avohilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints